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Abstract
Because of disease progression and heterogeneity in samples and single cells, biomarker
detection among subgroups is important as it provides better understanding on popula-
tion genetics and cancer causative. In this thesis, we proposed several structured latent
features based and multitask learning based methods for biomarker detection on DNA
Copy-Number Variations (CNVs) data and single cell RNA sequencing (scRNA-seq)
data. By incorporating prior known group information or taking domain heterogeneity
into consideration, our models are able to achieve meaningful biomarker detection and
accurate sample classification.
1. By cooperating population relationship from human phylogenetic tree, we intro-
duced a latent feature model to detect population-differentiation CNV markers. The
algorithm, named tree-guided sparse group selection (treeSGS), detects sample sub-
groups organized by a population phylogenetic tree such that the evolutionary relations
among the populations are incorporated for more accurate detection of population-
differentiation CNVs. 2. We applied transfer learning technic for cross-cancer-type
CNV studies. We proposed Transfer Learning with Fused LASSO (TLFL) algorithm,
which detects latent CNV components from multiple CNV datasets of different tumor
types and distinguishes the CNVs that are common across the datasets and those that
are specific in each dataset. Both the common and type-specific CNVs are detected
as latent components in matrix factorization coupled with fused LASSO on adjacent
CNV probe features. 3. We further applied multitask learning idea on scRNA-seq
data. We introduced variance-driven multitask clustering on single-cell RNA-seq data
(scV DMC) that utilizes multiple cell populations from biological replicates or related
samples with significant biological variances. scV DMC clusters single cells of similar
cell types and markers but varies expression patterns across different domains such that
the scRNA-seq data are adjusted for better integration.
We applied both simulations and several publicly available CNV and scRNA-seq
datasets, including one in house scRNA-seq dataset, to evaluate the performance of our
models. The promising results show that we achieve better biomarker prediction among
subgroups.
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Chapter 1
Introduction
Subgroup structures widely exist in genomic datasets. In population genetics, which
focus on the study of genetic variations within and between populations, samples are
normally analyzed in subgroups to learn distributions and changes in genotype and
phenotype frequency [1]. Genetic biomarkers, such as single nucleotide polymorphism
and copy number variation among sample subgroups contributes our understanding of
how evolution acts on genetic variation and, with the help of advanced sequencing tech-
nology, even allows data to be attached to the points at which populations start to di-
verge [2,3]. In cancer genome, somatic alternations, including small indels, copy number
variations, chromosomal rearrangements [4–6], are also observed differently on progno-
sis and frequency among patients with different tumor stages or tumor subtypes [7, 8].
It is critical to learn these subgroup specific biomarkers to better identify molecular-
based therapies [9,10]. Recently, single-cell RNA sequencing technology has emerged as
a promising genome-wide mRNA expression quantification method in individual cells
which identifies cell types by sub-populations of single cells [11]. Cell type specific
genes serve as biomakers to characterize sub-population structure and understand dis-
ease progression and mechanisms of transcription regulation [12,13]. Overall, because of
the discrepancies among samples, patients and single cells, biomarker detection among
subgroups is not only reliable and accurate but also biological meaningful.
In this thesis, we designed several machine learning based algorithms for biomarker
detection on two types of genomic data that have subgroup structures: DNA Copy
Number Variation data and single-cell RNA sequencing data. In this introduction,
1
2we briefly introduce these two datasets, present the current challenge, discuss related
methods and lastly propose several structured latent features and multitask learning
based algorithms to accurate detect biomarkers among subgroups.
1.1 Copy Number Variations
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Figure 1.1: Illustration of Copy Num-
ber Variation. In Normal case, copy num-
ber is 2, as shown in the middle figure. The
left figure shows a copy number deletion on
region B while right figure shows a copy
number duplication on region C.
Two copies of each gene are usually pre-
sented in a human genome. Variations of
this copy number of genes due to large-
scale DNA alternation, such as insertion,
deletion and duplication (of a large por-
tion of a gene) are called DNA Copy Num-
ber Variations (CNV). Figure 1.1 shows
an example of copy number deletion and
duplication.
CNVs account for a substantial pro-
portion of human genetic variations: they
are very common in human genome,
affecting more nucleotide content per
genome than single-nucleotide polymor-
phisms (SNPs). Previous studies show
that CNV could happen in any region of
genome and the percentage of an indi-
vidual’s chromosomes that exhibit CNVs
varies from 6% to 19% [14]. It is well known that due to the heterogeneity on popu-
lation level, human samples from different populations have different genetic variations
and show different phenotypes. However, there is limited knowledge of preserved CNV
patterns from specific population(s) as the population-specificity of CNVs are not well
understood [15].
In our previous study [16], we introduced a tool called SubPatCNV, which is an
approximate association pattern mining algorithm under a spatial constraint on the
CNV probe features that exhaustively detect large, common CNV patterns across any
3sample subsets. We applied it on Hapmap data [17] that contains 270 samples from 4
different populations and the results show that 55% to 70% of the patterns detected
by SubPatCNV are population-specific. These highly population specific patterns indi-
cate that, by incorporating populations information as a prior knowledge, it is possible
that more accurate of population-differentiation CNVs can be detected and even the
evolutionary relations among the populations could be depicted.
CNVs also have been found extremely common in human cancer genome [18,19] and
it is believed that CNVs play significant roles in tumorigenesis [14, 20]. Identification
and systematic analysis of CNVs can provide important insights into the cellular defects
that are cancer causative and suggest potential therapeutic strategies.
In cancer research, one of the main tasks is to identify the CNVs and correlate
them with diseases. Due to cancer heterogeneities among the patients [21, 22], even
the genomic datasets from the same cancer type patients could be very different. For
example, the patient samples grouped by different tumor grades, stages or survival and
metastatic status exhibit different CNV patterns. The samples in each or some of the
groups might be associated with CNVs that are only discovered from the samples in
the same group(s). This is supported by previous study [8] which shows that low and
medium grade tumors of bladder cancer generally contain few changes. Thus, it is
more biologically interesting to identify CNV patterns for the samples under groups
given by prior information to understand disease progression and discover personalized
treatment.
1.2 Single Cell RNA-seq
In recent years, single cell RNA sequencing (scRNA-seq) technology has emerged as
a promising individual cell genome-wide mRNA expression quantification method [11].
Traditionally, to measure molecular states, bulk RNA-seq methods take average of signal
values from millions of cells. These bulk methods overlook the differences in cell popu-
lation and treat cell population to be homogeneous. However, this could misrepresent
signals of interest [23,24] as study [25] show that cell heterogeneity is not only attributed
by mutation in tumor studies, but also observed in generically identical cells under the
4same environment. To solve this problem, scRNA-seq technology are developed to iden-
tify cell heterogeneity. With the identification of cell types and measurement of gene
expression distribution, we now have the chance to characterize subpopulation struc-
ture, understand disease progression and mechanisms of transcription regulation [25].
Furthermore, RNAs with b may be undetectable in traditional cell-averaging method
as they may only express in a small number of cells which related with uncommon or
short-time cell types. These RNAs may still play an important role and with the help
of scRNA-seq technic with sufficient number of single cells, the measurement become
possible [11].
Currently, scRNA-seq protocol contain the following steps: isolation of single cell
and RNA, reverse transcription, amplification, library generation and sequencing. How-
ever, a variety of noise and bias could be introduced in each step [11]. Besides those
issues also exist in bulk RNA-seq, there are some distinct problems in scRNA-seq, both
from biological sources, such differences among cells in cell-cycle stage or cell size, and
technical/systematic sources, such as capture inefficiency, material degradation, sample
contamination, amplification biases, GC content, sequencing depth, etc. For example,
due to the tiny amount of cell materials [26], heavily amplification is need before se-
quencing. PCR are mostly popularly used, however, any bias introduced by PCR could
be exponentially amplified. Other amplification technic, such as in vitro transcrip-
tion [23, 27], which is proposed to avoid PCR sequence bias, also suffer from certain
transcribed inefficiency and sequence drop-out. So noise and bias is unavoidable in
current amplification step. These potential issues lead to uneven coverage on entire
transcript and as result, abundance of zero regions are observed [28]. When multiple
single cell populations are available. as shown in Figure 1.2. , there could be significant
variances among them due to experiment technical bias. Variance could be more sig-
nificant when different samples are used for generating each single cell populations as
sample to sample confounder could be another issue need to be considered.
1.3 Challenges and Objectives
Currently, there are still many challenges on learning with CNV and scRNA-seq data,
especially for biomarker detection among groups.
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Figure 1.2: Illustration of single cell
RNA-seq data from multiple cell pop-
ulations. Each color circle dot in the mid-
dle column indicate one single cell, while
different color indicate different cell types.
Each sample on the left generate many sin-
gle cells. Cell populations from different
samples are normally inconsistent, as shown
in gene expression profiles on the right.
1. Many DNA copy-number variations
are known to lead to phenotypic varia-
tions and pathogenesis. With the increas-
ing number of avalible samples, it is im-
portant to consider both the similarity
and the heterogeneity among the amples
to accurately detect CNV patterns. Ex-
isting methods such as FLLat [29] ignore
the fact that patient samples with differ-
ent phenotypes show different frequencies
and patterns of CNVs. These methods
tend to miss the CNVs specific to subsets
of samples. Similarly, on population stud-
ies, despite the prevalence of CNVs in hu-
man genomes and previous studies showed
that the reported CNVs tend to be more
common in closely related human popu-
lations [14], only limited effort has been
made on CNV analysis in the context of
human population evolution [15, 30, 31].
Understanding the CNV diversities across
populations is a computational challenge
because CNV patterns are often present in several related populations and only occur in
a subgroup of individuals within each of the population. Previous studies limit on pair-
wise comparison, so groups specific CNVs, which could be used as Ancestry Informative
Markers, are still waited to be explored.
2. Application of transfer learning on CNV analysis across multiple cancer types is
promising since CNVs are a hallmark of cancer genomes. However, it is still a challenge
to study how CNVs play a role in driving tumorgenic mechanisms that are either uni-
versal or specific in different cancer types. Previous studies suggested that many copy
number alternations might be found across different cancer types, but most previous
computational research work focused on developing models for identifying individual
6CNV events from CNV samples of a single cancer type. [32] studied 17 cancer types
with at least 40 samples in each cancer type and reported that about 80% somatic copy
number alternations found in one cancer type can also be found in pooled analysis ex-
cluding that cancer type. These common and type-specific CNVs can potentially reveal
unknown cancer mechanisms in the light of cross-cancer-type analysis. However, cur-
rently there is no unified mathematical model to simultaneously detect the CNV events
common or specific to multiple cancer types from CNV array datasets.
3. As a new technology, there are some challenging in performing scRNA-seq ex-
periment and downstream analysis. Compared to bulk RNA-seq experiments, typical
scRNA-seq experiments have more experimental bias and lower read coverage making it
more difficult to discover relevant biological variation. Currently, there are existing stud-
ies on identifying cell sub-population and further characterizing differential expressed
genes on learned cell clusters. Some of the methods directly came from traditional
bulk RNA-seq analysis and classical dimension reduction algorithms, such as Principal
Component Analysis [33–35], hierarchical clustering [36], t-SNE [37–39], Independent
Component Analysis [40] and Multi-dimensional Scaling [41]. Other methods focus on
special properties of scRNA-seq data, such as high variance and uneven expressions.
For example, SNN-Cliq uses ranking measurement [42] to get reliable results on high
dimension data; [43] proposed a special dimension reduction method to handle large
amount zeros measurement on scRNA-seq; [44] propose a Latent Dirichlet Allocation
based model with latent gene group to measure cell to cell distance. Mixed multiple
batch strategy is also proposed [36,45] to reduce the technical variance but with limited
improvement. Nevertheless, there is no model designed specifically to learn cell types
all together on multiple cell population scRNA-seq data.
1.4 Related methods
To identify biomarkers across many samples, latent feature methods are widely used.
Transfer learning technic is also applied when there are several related domains with
heterogeneity, such as cross cancer CNV studies or single cell sequencing data with
multiple cell populations In this section, we briefly discuss these two related methods.
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Figure 1.3: Illustration of latent feature model. A feature by sample genomic
profile matrix can be factorized into latent features and corresponding coefficients with
low-rank matrix factorization.
1.4.1 Latent feature learning with low-rank matrix factorization
For multi-sample CNV detection, all samples are analyzed simultaneously in one op-
timization framework. [46] and [47] proposed to identify the amplification or deletion
regions shared across all samples as follows: for N samples with M copy number fea-
tures, we can solve the following optimization problem:
min
U∈RM×N
‖X − U‖2 + λ
M−1∑
m=1
‖Um+1,• − Um,•‖ ,
where X is the M × N CNV profile matrix, U is the de-noised segmentation approxi-
mating X and Um,• is the mth row of U . A fast group least-angle regression (LARS)
algorithm can be applied to solve the optimization framework approximately to de-
tect shared change-points from the multiple CNV profiles. Since the change-points are
detected from all profiles in the framework, it is expected to be more accurate than
detecting change-points independently from each CNV profile.
8Under the same motivation that CNVs are usually shared by multiple samples,
instead of approximating the profile matrix X by a segmentation matrix of the same
size, another more advanced modeling is to detect the shared CNVs as latent fused
features by low-rank matrix factorization decomposed from X, as shown in Figure 1.3.
In this model, each samples is approximated as linear combination of latent features.
Another widely used dimensionality reduction method principal component analysis
(PCA) can decompose X into orthogonal principle components. The projection of X to
a low-dimensional space obtains coefficients of the principle components to preserve the
variance. However, practically it is not feasible to interpret the principle components
as CNVs since the principle components cannot be explained as CNV patterns without
fusing the adjacent features with lasso.
More recently, a Fused Lasso Latent Feature Model (FLLat) was proposed by [29]
for detecting latent CNV components. Again, for the profile matrix X with N samples
and M probes, FLLat decomposes it as a weighted sum of a fixed number of latent
feature components, which are smoothed by fused lasso. The corresponding optimization
problem for FLLat is
min
U,V
N∑
n=1
M∑
m=1
(
Xmn −
K∑
k=1
UmkVkn
)2
+ λ1
K∑
k=1
M∑
m=1
|Umk|
+λ2
K∑
k=1
M∑
m=2
|Umk − Um−1,k|
subject to
∑N
n=1 V
2
kn ≤ 1 for each k, where K is the number of latent features and Xmn
is the log intensity ratio of the mth probe for the nth sample. This model minimizes
the sum of the square errors as well as the fused lasso penalties on the latent feature U .
It is clear that the model does not assume any structure on the weights of the latent
fused lasso components V so each learned latent components are still according to all
the samples which are not subgroup specific.
1.4.2 Multitask learning/Transfer learning
Traditional machine learning system works within one domain: it either makes pre-
dictions by learned models from training data or direct learns with unlabeled data.
However, in real world application, it is often expensive or impossible to collect labels
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Figure 1.4: Illustration of Multitask Learning. On the left, traditional machine
learning methods are shown which apply learning technic on each domain individually.
On the right, multitask learning uses knowledge as bridge to connect all the domains
and improves learning system for each domain.
from certain domain data, but information from similar or related domains are available.
Transfer learning, which solve a task, such as classification or clustering in one domain
by utilizing information from other domains that may be in a different feature space or
follow a different data distribution, can greatly improve the performance of learning.
Commonly, transfer learning are refer to the case when knowledge is transferred
from source domains to target domains. Technique that learn task all simultaneously
among all the domains are called multitask learning and sometimes is considered to be
a special case of transfer learning [48]. In this thesis, we use term ”transfer learning”
and ”multitask learning” interchangeably. The difference between traditional machine
learning and multitask learning is shown in Figure 1.4.
As the feature space and data distribution could be different among domains, so a
feature selection or feature reduction procedure is needed to extract the common and
sharable information among them to minimize domain divergence. By utilizing shared
knowledge, classification or regression error in each task could be reduced as well. Cur-
rently there are many transfer learning studies: some are designed for improvement only
on single target domain [49], some work for all the domains [50,51]. Knowledge transfer
combines with sparse feature learning [52], SVM [53], kernel-based method [54] and
Procrustes analysis-based method [55] are also developed. [56] proposed a method that
extract the discriminative information from labelled data and use it for unsupervised
dimensionality reduction. By repeating this procedure, this method iteratively updates
the clustering results to get most discriminative subspace and optimal clustering result.
10
However, this proposed method required some labelled information in source domain to
work. In paper [57], a feature reduction method is proposed to minimize the distance
between distributions of the data in source and target domains. Even though the feature
reduction method do not require label information, it cannot easily extended to multiple
domains. Also, when data in each domain are severely suffered by systematic bias, a
simple feature selection or reduction is not enough as domains may have no clear shared
knowledge. For example, in multiple cell population single cell data, each domains may
contain several cell types but assuming the data of certain cell type to be similar across
different domains is a hypothesis that could be too strong to be true.
1.5 Contributions
Considering that 1) subgroup structures exist in both CNV data and scRNA-seq data;
2) cross-domain heterogeneities such as human population, cancer types and single cell
samples; we proposed several structured latent features and multitask learning based
methods as follows:
First, we cooperated prior-known sample relationship and developed a structured
latent features based method for high accurate CNV pattern detection on population
study. We proposed a tree-guided machine learning algorithm to detect population-
differentiation CNVs among populations organized by a phylogenetic tree of human
populations. Utilizing the evolutionary relation in the human population tree, the
algorithm treeSGS discovers sets of CNV markers associated with the branches of the
tree such that there exists a subgroup of individuals in each population below the branch
exhibiting the preserved CNV patterns from the ancestral population. In the study of
1179 samples from the 11 populations in Hapmap3 and 1000-genome-project data, we
validated the accuracy of the algorithm in detecting a list of candidate AIM CNV
markers that not only are population-differentiation but also depict the evolutionary
relations among the populations.
Then, to study CNVs across different cancer domains, we proposed a Transfer Learn-
ing with Fused Lasso model TLFL to detect latent CNV features from CNV datasets
of multiple cancer types, in which each cancer type can be regarded as one domain
in transfer learning. Common latent CNV features are used as a bridge to transfer
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knowledge among different cancer domains along with the domain-specific components
for each cancer type to explain the observed CNV datasets. To represent the pattern
of CNV events, fused lasso is applied on each latent CNV features to preserve the spar-
sity and block structure. By using alternating optimization to solve the TLFL model,
common latent features and domain specific features could be detected from multiple
domains. Compared with a baseline method without using knowledge transfer, TLFL
is more robust and identifies more accurate latent CNV components in simulations and
experiments on real arrayCGH CNV datasets and SNP genotyping array datasets.
Finally, we applied multitask learning method on single cell RNA sequencing data
with multiple cell populations. We introduced a multitask learning method with an
embedded feature selection to capture most the differentially expressed genes among
cell clusters across all cell populations to achieve better single-cell clustering simulta-
neously. The key to doing this is the use of multiple single-cell populations available
from biological replicates or related samples with significant biological variances such
as samples cultured independently or obtained from different patients. We proposed a
variance-driven multitask clustering of single-cell RNA-seq data (scV DMC) algorithm
that utilizes expression patterns of different single-cell populations with shared cell-type
markers for better integration. Applied to two real single-cell RNA-seq datasets with
several replicates, scV DMC detected more accurate cell populations and known cell
markers than pooled clustering and several other recently proposed scRNA-seq clus-
tering methods. scV DMC, applied to in-house Recessive Dystrophic Epidermolysis
Bullosa (RDEB) scRNA-seq data, revealed several interesting cell types and markers
that were previously unknown.
1.6 Outline
The rest of the thesis will be organized into four chapters:
• In Chapter 2, we describe treeSGS algorithm which use population tree as prior
knowledge to discover population-different CNV patterns.
• Chapter 3 describes TLFL algorithm that identify common and specific CNVs on
cross-cancer studies.
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• Chapter 4 describes a variance driven multitask clustering method scV DMC on
multiple cell population scRNA-seq datasets.
• Finally, we summarized all these algorithms and models and then discussed pos-
sible future work in Chapter 5.
Chapter 2
Tree-guided group selection for
CNV detection
2.1 Introduction
Two copies of each gene are usually present in a human genome. Variations of this
copy number of genes due to larger-scale DNA alternation, such as insertion, deletion
and duplication (of a large portion of a gene) are called DNA copy number variants
(CNVs). CNVs are very common in human genome, affecting more nucleotide content
per genome than single-nucleotide polymorphisms (SNPs). Previous studies showed
that CNV could happen in any region of genome and the percentage of an individual’s
chromosomes that exhibit CNVs varies from 6% to 19% [14].
In the literature [58, 59], there have been intensive studies on the genetic diversity
among human populations by SNP association analysis. However, despite the preva-
lence of CNVs in human genomes and that previous studies showed that the reported
CNVs tend to be more common in closely related human populations [14], only lim-
ited effort has been made on CNV analysis in the context of human population evolu-
tion [15, 30, 31]. A recent study in [15] performed global CNV population stratification
on 236 human genomes from seven continental population groups and reported many
population-differentiation CNVs by pairwise comparison between the populations.
In this chapter, we propose a tree-guided sparse group selection algorithm (treeSGS)
to discover common CNVs from subgroups of individuals across populations organized
13
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Figure 2.1: Factorization of CNV genotypes guided by human population
tree. The genotype matrix X (top left) is factorized into latent CNV profiles matrix U
(bottom left) and the coefficient matrix V (bottom right). Each column in V indicates
a sample. The population tree (top right) shows the hierarchical relation of three
super populations, east Asian(EAS), European(EUR) and African(AFR). There are
nine latent CNV profiles shown in different colors. Their corresponding coefficients in
V are shown in the same color. Each pie chart at a node shows the presence of the
CNV profiles under the branch. The coefficients show consistent patterns with the
hierarchical structure in the tree.
in the phylogenetic tree of human populations. Based on the human population tree,
the focus of the algorithm is to detect CNV profiles representing the collections of CNV
15
events introduced at each branch of the tree such that there exists a subgroup of individ-
uals in each population below the branch exhibiting the preserved CNV patterns from
the ancestral population. By associating CNV signatures with the internal nodes as well
as the leaves of the population tree, treeSGS algorithm incorporates the evolutionary
relations among the populations to recover the history of CNVs.
Figure 2.1 shows a toy example with 12 samples from east Asian (EAS), European
(EUR) and African (AFR) organized in a phylogenetic tree, where EAS and EUR
populations more recently differentiated from each other than AFR. The genotype data
of the 12 samples can be factorized into CNV profiles and coefficients such that each
sample is a linear combination of the latent CNV profiles weighted by the coefficients.
The non-zero coefficients shows the selection of a CNV profile in a sample. The light
grey profile is selected by some individuals from EAS and EUR and the yellow profile
is selected by individual from all three populations while the other seven profiles are
specific to one of EAS, EUR and AFR populations. The organization of the coefficients
is consistent with the tree since each CNV profile corresponds to population groups
organized by the nodes in the tree, e.g. the light grey profile corresponds to the parent
node of EAS and EUR and the yellow profile corresponds to the root node. The yellow
profile represents the earliest CNV events in this example which thus occurs in all the
three populations. Detecting CNVs in the context of a tree among populations is more
appropriate setting than pairwise comparison between populations [15].
With the treeSGS algorithm, we studied the 1179 samples from the 11 populations
in Hapmap3 CNV genotype data based on the human population tree built with SNPs
shown in Figure 2.2. In the experiments, treeSGS more accurately identifies CNV
signatures of each population and the collection of populations in each branch of the
human population tree than several other methods. We validated each CNV profile
and their occurrence in the populations by their consistency among the family trios in
Hapmap3 samples and the SNP characterizations of the CNV regions by populations.
We also further compared the other population-differentiation CNV signatures reported
in other recent studies with the detected CNV signatures by treeSGS to show that the
CNV signatures are more accurate annotations describing the differentiation between
groups of populations.
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Figure 2.2: Phylogenetic tree of 11 human populations. 3 East Asian populations
(red), CHB: Han Chinese in Beijing, China; CHD: Chinese in Metropolitan Denver, Col-
orado; JPT: Japanese in Tokyo, Japan, 4 African populations (green), ASW:African an-
cestry in Southwest USA; LWK: Luhya in Webuye, Kenya; MKK: Maasai in Kinyawa,
Kenya; YRI: Yoruba in Ibadan, Nigeria and 2 European populations (yellow), CEU:
Utah residents with Northern and Western European ancestry from the CEPH collec-
tion; TSI: Toscani in Italia. MXL:Mexican ancestry in Los Angeles, California and
GIH:Gujarati Indians in Houston, Texas. are grouped with the European populations.
2.2 Methods
In this section, we first present the model, and then describe treeSGS algorithm and
each major profile of the algorithm.
2.2.1 Tree-guided sparse group selection model
Let X ∈ Rm×n be the CNV feature by sample matrix, where m is the number of CNV
features and n is the number of samples. Let U ∈ Rm×K be the profile matrix and
V ∈ RK×n be the coefficient matrix, where UV is a factorization of X and K is the
number of latent CNV profiles.
For a given binary population tree Tree(g), let g = {g1, g2, . . . , g2L−1} represent the
2L − 1 nodes in the tree, where {g1, g2, . . . , gL} are the leaf nodes (populations) and
{gL+1, gL+2, . . . , g2L−1} are the internal nodes. We define a function F (gi) to output the
set of samples in which a sample belongs to the population gi when gi is a leaf otherwise
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a population that is a descendant node of gi,
F (gi) =
{p|p ∈ gi} if i ≤ L∪j{F (gj)|desc(gi, gj)} otherwise,
where p denotes an individual sample and desc(x, y) denotes y is a descendant node
of x. In the first case, gi is a population and F (gi) is the set of all the individuals in
the population gi. In the second case, gi is an internal node and each gj denotes a leaf
descendant of gi. F (gi) is the union of all the individuals in each population gj .
We next define a split of Tree(g) to partition the populations with respect to a
certain CNV profiles k as split(g, k). split(g, k) is a subset of g denoted as {gk1 , ..., ...gkz}
where z ≤ L such that the following two conditions are satisfied,
(1)F (gki) ∩ F (gkj ) = ∅, ∀gki , gkj ∈ split(g, k)
(2) ∪gki∈split(g,k) F (gki) = ∪
L
l=1F (gl)
(2.1)
The two conditions guarantee that split(g, k) denotes a set of branches in the tree that
exactly partition the n samples by the partition of the leaf nodes (populations) in each
branch.
Based on the above definitions, the regularization framework of treeSGS is defined
as follows,
minimize
U,V
||X − UV ||2F + λ
∑
k
|U•,k|1
subject to V  0
Vk,• × V Tk,• = 1, k = 1, . . . ,K
Vk,F (gki )
× bk,F (gki ) = 0,
∀gki ∈ split(g, k) for k = 1, . . . ,K,
(2.2)
where |U•,k|1 is the L1 norm on U•,k (|U•,k|1 =
∑
i |Ui,k|) for sparse CNV signals;
Vk,F (gki )
is a sub-vector of Vk,• indexed with F (gki) and bk,F (gki ) is a corresponding
binary indicator. If bk,F (gki )
= 1, then Vk,F (gki )
will be a 0 vector. bk,F (gki )
acts as a
selection indicator which 0 means the corresponding group F (gki) is selected in vector
Vk,•. We will discuss how to choose bk,F (gki ) in the next section. The treeSGS model is
the tree-guided version of the sparse group selection model in [60] (formulation given in
the supplementary document).
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2.2.2 TreeSGL algorithm
The main framework of treeSGS algorithm is shown in Algorithm 5. The algorithm
alternatively optimizes the CNV profiles U and the coefficients V until convergence.
Algorithm 1 treeSGS algorithm
1: Input: X,Tree(g), τ, θ, λ,K
2: U = PCA(X,K)
3: repeat
4: repeat
5: for k = 1, 2, . . . ,K do
6: compute w(k) by eqn 2.6
7: split(g, k) = EntropyCut(Tree(g), w(k), τ)
8: bk,• = SparseGrpSelect(w(k), split(g, k), θ)
9: Solve Vk,• in eqn 4.2
10: end for
11: until V converge
12: Solve U in eqn 4.3
13: until U and V converge
14: return U and V
TreeSGL algorithm takes the CNV sample data X, the population tree Tree(g) and
four hyper-parameters as inputs. The four hyper-parameters are K: the total number of
CNV profiles, λ: the weight on the LASSO regularizer and τ : the cutoff for computing
split(g, k), θ: the weight ratio for group selection, which will be explained in the next
sections. At line 2, the CNV profiles U are initialized by the first K principle profiles
of X. The repeat-until loop between line 3-13 iteratively solve V or U with the other
fixed. The repeat-until loop between line 4-11 iteratively solve V with the sparse group
selection computed by the for-end loop between line 5-10.
solve U:
At line 12, when V is fixed to solve U , the subproblem to optimize is given as,
minimize
U
||X − UV ||2F + λ
∑
k
|U•,k|1, (2.3)
In this objective function, λ > 0 weights the LASSO terms. This function is solved
column-wisely on U as the standard L1 LASSO linear regression problem [61] by multi-
task extension [62] with a fast convergence rate of O(1 ) where  is a desired accuracy,
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and per-iteration time complexity O(K2m). If treeSGS is directly applied to arrayCGH
or genotyping array probes, it is also possible to add a fused LASSO penalty as the
graph-guided fusion penalty algorithm [62],
λ1
∑
k
m∑
i=1
|Ui,k|+ λ2
∑
k
m∑
i=2
|Ui,k − Ui−1,k|, (2.4)
where the LASSO and fused LASSO penalties will introduce sparse segmented CNV
signals in the profiles.
solve V:
At line 9, when U is fixed, V can be solved column-wisely. For each k, we have the
following subproblem,
minimize
Vk,•
||Xˆk − U•,kVk,•||2F
subject to Vk,•  0
Vk,• × V Tk,• = 1
Vk,F (gki )
× bk,F (gki ) = 0, ∀gki ∈ split(g, k),
(2.5)
where Xˆk = X−U•, 6=kV 6=k,• is the residue matrix of X after removing the contributions
from the other profiles. To solve each column of V , we will need to obtain the tree
split by grouping the populations and then select the groups with bk,F (gki )
, which are
described in the following section.
2.2.3 Tree splitting and sparse group selection
The core idea of introducing the population tree is to provide a strategy of grouping the
populations intelligently such that the discovered CNV profiles can depict the relations
among the populations in the tree. To achieve the goal, we first define vector w(k) for
each CNV profile to denote the importance of the CNV profile k to the construction
error, in which each element of w(k) corresponds to each sample’s contribution.
w(k) =
UT•,kXˆk
U•,kTU•,k
. (2.6)
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Figure 2.3: Illustration of tree-based split of populations by CNV profiles. At
the top, a population tree Tree(g) with five populations (solid blue circles) and four
ancestral nodes (hollow blue circles) is shown. Below, three series of w(k) denoting the
contribution of each sample to the CNV profile are plotted as the black curves. The
vertical blue dash line on w(k) plots indicates the separations of the individuals from
the five populations at the leaf nodes while the red lines in the bottom plots indicates
the groups found by EntropyCut. The red “×” marks nodes for the tree split. The
grey area are the selection of highly weighted group(s) based on SparseGrpSelect.
In the above equation, UT•,kXˆk returns the inner product similarity between U
T
•,k and
each column of Xˆk. The higher the similar, the more useful U•,k to the reconstruction
of Xˆk w
(k) differentiates the populations into related vs non-related groups with respect
to the CNV profile k. To illustrate how the populations can be grouped in the true
structure, three examples of w(k) are shown in Figure 2.3. In the left example, the five
populations can be grouped as (1, 2, 3), (4) and (5), and thus, the tree splitting will be
introduced at the internal node 8 and 9; in the middle example, the populations can be
grouped as (1,2), (3) and (4,5), and thus, the splitting will be at node 7 and node 9. In
the right example, the groups are (1), (2), (3) and (4,5), and thus, the splitting will be
21
at node 9, node 7 and node 6. After the splitting, SparseGrpSelect() is applied to select
the top groups representing at least θ percent of all the contribution to reconstruction.
In the three examples, {F (g4)}, {F (g3), F (g8)} and {F (g1), F (g3)} are selected from left
to right. Accordingly, the corresponding bk,F (gki )
are set to be 0 to select the variables
for learning.
Algorithm 2 EntropyCut
1: Input: Tree(g), w(k), τ
2: for each parent-children triple {p, l, r} in Tree(g) do
3: use eqn 2.7 or 2.8 for density estimation.
4: calculate entropy(w
(k)
F (gp)
), entropy(w
(k)
F (gl)
) and entropy(w
(k)
F (gr)
) by eqn 2.9.
5: calculate InfoGain(p, l, r) by eqn 2.10.
6: if InfoGain({p, l, r}) ≥ τ then
7: split node[p]=true
8: else
9: split node[p]=false
10: end if
11: end for
12: for each g ∈ {gL+1 . . . g2L−1} and split mark[g] do
13: split node[ancestor(g)]=true
14: end for
15: split(g, k) = {groot}
16: for each g in breadth-first traversal of the nodes do
17: if g ∈ {gL+1 . . . g2L−1} and split node[g] then
18: split(g, k) = split(g, k) - {g}
19: split(g, k) = split(g, k) ∪ {left(g), right(g)}
20: end if
21: end for
22: return split(g, k)
Tree splitting by EntropyCut():
At line 7 in Algorithm 5, EntropyCut returns the tree partition split(g, k) for each
CNV profile k given the sample reconstruction vector w(k) and the tree structure
Tree(g). For every internal node p ∈ {gL+1 . . . g2L−1} and the two children node
l = left(p) and r = right(p) as a triple {p, l, r}, we calculate their corresponding entropy
entropy(w
(k)
F (gp)
), entropy(w
(k)
F (gl)
) and entropy(w
(k)
F (gr)
). The procedure EntropyCut is
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described in Algorithm 2. The algorithm applies Information Gain to calculate if split-
ting the samples into two groups under a particular branch will increase the overall
information gain significantly.
First at line 3 in the algorithm, we obtain a density estimation of each w(k) with
either histogram and Gaussian kernel estimator. Denote the elements in the vector
w
(k)
F (g) = {xt}t=1,2,,...,M assuming IID drawing from p(x). For the histogram of bin size
h,
pˆhist(x) =
# {of xt in the same bin as x
Mh
}. (2.7)
For Gaussian Kernel estimator with bandwidth hˆ,
pˆ(x)gk =
1
Mh
M∑
t=1
1√
2pi
exp
[− (x− xt)2
2hˆ2
]
. (2.8)
Based on the density estimation pˆ(x), entropy can be calculated as
entropy(X) = −
∑
j
pˆ(xj) log pˆ(xj), (2.9)
where xj is evenly sampled with in the input range. Note that the sampling points in
equation 2.7 or 2.8 for calculating entropy of note p, l and r are all within the range of
w
(k)
F (gp)
since w
(k)
F (gl)
and w
(k)
F (gr)
are both sub-vectors of w
(k)
F (gp)
.
At line 5, the information gain of splitting at a triple {p, l, r} is calculated as
InfoGain({p, l, r}) = entropy(w(k)F (gp))
− |gl||gp|entropy(w
(k)
F (gl)
)
− |gr||gp|entropy(w
(k)
F (gr)
)
(2.10)
At line 6-10, the information gain is compared with the threshold. If InfoGain({p, l, r}) ≥
τ , w
(k)
F (gl)
and w
(k)
F (gr)
form two distinct distributions and thus w
(k)
F (gp)
needs to split; oth-
erwise, if InfoGain({p, l, r}) < τ , w(k)F (gl) and w
(k)
F (gr)
are similar and there is no need to
split.
After all the triples are checked and the internal nodes are marked as split or non-
split, we mark all the ancestor nodes of splitting nodes as split (line 12-14 in Algorithm
2) since it is necessary to split all the parent groups before splitting a more specific
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group. After this step, a breadth-first traversal of the tree is applied to choose the most
specific splitting nodes for generating the partition of the populations at line 15-21. The
time complexity of EntropyCut is O(NL+ L logL).
Sparse group selection with SparseGrpSelect():
Algorithm 3 selects the top groups from split(g, k). First, in the for-loop between line
2-3, the normalized group weight for each w(k) are calculated as below:
hki =
||w(k)gki ||√|gki | , gki ∈ split(g, k).
The selection indicator variable b(k)=1 for initialization. Next, the normalized group
weights are sorted in descending order at line 5. The top groups accounts for at least θ
of total group weights are selected and their corresponding binary indicator b(k) is set
to be 0 in the repeat-until-loop at line 7-9. The time complexity of the procedure is
O(N + L logL).
Algorithm 3 SparseGrpSelect
1: Input: w(k), split(g, k), θ
2: for every gki ∈ split(g, k) do
3: hki =
||w(k)gki ||√|gki | , bk,F (gki ) = 1
4: end for
5: Sort hki , i = 1, 2, . . . in descending order as hkˆi , i = 1, 2, . . .
6: l = 1
7: repeat
8: l = l + 1, bk,F (gkˆl )
= 0
9: until
∑l
i=1 hkˆi∑
i hki
> θ
10: return bk,•
2.2.4 Related work
Tree-SGL is based on the Sparse Group Selection on LASSO (SGL) [60], which don’t
utilize tree structure but instead only works on non-overlapping groups for cancer CNV
data analysis. SGL performs the same group selection without the tree split procedure as
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treeSGS. Therefore, SGL will model the 11 population simply as 11 groups for selection
ignoring their relations. The complete description of the SGL model can be found in
the supplementary document. Another alternative approach to introduce tree structures
among variables is tree-guided group LASSO [62]. Tree-guided group LASSO models a
path in the tree structure as a group and the coefficients in the same group are smoothed
by 2-norm. Since the paths in a tree overlaps, the tree-guided group LASSO problem is
more difficult to solve. We adopted the tree-guided group LASSO for our problem by
coupling the factorization term with the group LASSO penalty on each path from each
leaf to root. The complete formula is presented in the supplementary document and we
applied tree LeastR function in the SLEP package to implement the alternative model
(SLEP-GL) [63].
2.3 Experiments
In the experiments, we applied treeSGS method on Hapmap phase 3 CNV genotype
data [17,64], which contains 1179 samples and 841 autosome CNVs from 11 populations.
The original data are coded with integers from 0 to 5 representing copy numbers and we
subtract 2 for the 2 copies for normal. After the transformation, value of -1 represents
a heterozygous deletion, and -2 represents a homozygous deletion, and positive integers
indicate the additional duplications.
We also obtain all SNP genotypes on the same samples [64] and used SNPphylo tool
[65] to generate a phylogenetic tree with sample-wise relationships shown in figure 2.2.
The full phylogenetic tree organizing all the samples can be found in the supplementary
figures.
TreeSGL is compared with SGL and tree-builded group LASSO methods in the
experiments. We evaluated how well each method detect group-specific CNVs that are
consistent with the population tree, the SNP data and the family trio annotations in
the Hapmap3 samples. In addition, we also collected population-differentiation CNVs
detected from different samples from two other studies for further validation of the
group-specific CNVs detected by treeSGS [15,66].
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Figure 2.4: Visualization of CNV profiles and coefficients by populations. The
coefficient matrices V computed by SGL and treeSGS (Gaussian Kernel Estimator with
τ = 0.0001) are shown in (a) and (b), respectively. The CNV profiles learned by treeSGS
is shown in (c). Hierarchical clustering is applied to cluster the populations by the mean
of V across the samples in each populations.
2.3.1 Interpreting CNV profiles and coefficients
Figure 2.4 shows the visualization of the factorization of Hapmap3 CNV data organized
by populations. The original CNV data X (841 by 1179) is factorized into V , the profile
matrix of 60 profiles (841 by 60) and U , the coefficient matrix (60 by 1179). After
the factorization, we represent each sample by the 60 CNV coefficients as features to
cluster the 1179 samples to construct a population tree for comparison with the known
population tree. Figure 2.4(a) and (b) show the coefficient matrix by SGL and treeSGS.
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λ = 0.8 was chosen for both treeSGS and SGS for better visualization. Other choices
of λ leads to similar patterns. Hierarchical clustering of the coefficient matrix is also
shown. Without using the tree structure, SGL generate highly inconsistent population
relations compared with the ”ground truth” tree structure (Figure 2.2) in clustering the
east Asian groups (CHB, CHD, JPT) and the extended European group (CEU, TSI,
MXL and GIH). TreeSGS use tree structure as guidance and reproduced the population
tree with the sparse coefficients except the African popultions. Note that there is weak
consensus on the hierarchical clustering of the African populations due to the individual
diversity and longer history of the populations. Figure 2.4(c) shows the 60 profiles. Each
non-zero entry represent a deletion/insertion the 841 loci. The CNVs captured in the
same profile indicate possible the same origin or similar evolutionary trace since the
CNVs co-occur in many samples.
2.3.2 Validating CNV genotypes by family trios
We validated the CNV genotypes by the 155 father-mother-child trios in Hapmap3 data
in 5 populations (10 in ASW, 44 in CEU, 28 in MKK, 23 in MXL and 50 in YRI).
With each CNV profile representing a CNV genotype, its corresponding coefficients
on the samples classify the samples into two groups as with/without the genotype. A
trio is considered as likely inconsistent with the CNV genotype if either 1) the child
has the genotype but neither of the parents have or 2) the child has not the genotype
but both parents have. By dividing the samples in the same population as the trio by
the quadratic mean of the coefficients of each CNV genotype, we report the average
number of inconsistent trios in the CNV genotypes in Figure 2.5. TreeSGL, SGL and
SLEP-GL are tested under different choices of the number of profiles K and other hyper-
parameters. TreeSGL was applied with both histogram density estimation (Figure 2.5a)
and Gaussian kernel density estimation (Figure 2.5b)
In Figure 2.5, the general trend is that asK increases the number of inconsistent trios
gets lower as expected because more CNV profiles could capture more low frequency
CNVs that are often more consistent among family. SGL performed worst among all
the three methods under a sparse solution with no information from the population tree
for grouping. TreeSGL improves the results of SGL by the population tree information.
The hyper-parameter θ controls the group selection ratio on SGL and treeSGS methods.
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Figure 2.5: Average number of inconsistent trios in CNV genotypes. treeSGSb
and treeSGSg denote treeSGS applied with histogram (a) or Gaussian Kernel Estimator
for density estimation (b) respectively. The plots on the left show the results of varying
the number of CNV profiles K with fixed λ = 0.8 for SGL and treeSGS. The plots on
the right show the results of varying the λ with fixed K = 60.
The right plots show that treeSGS is consistently better than SGL method when θ is
moderate or large indicating that the reasonably combined groups under tree branches
are selected by treeSGS. When the splitting threshold τ gets larger, treeSGS generates
denser results and eventually, the performance is comparable or slightly better than
SLEP-GL. The results demonstrate that treeSGS provides a combined advantages of
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Figure 2.6: Comparing CNV events meaningfulness by p-value on classifi-
cation accuracy of different methods under different K. log10 of p-value is
reported. SLEP-GL method used 10% and 20% of maximum penalty parameter. TBLb
and TBLg indicate TBL method with histogram and Gaussian Kernel Estimator for
density estimation respectively. Both SGL and TBL use θ = 0.8.
sparsity and higher sensitivity.
2.3.3 Cooccurrence of CNV and SNP genotypes
To validate whether the CNV genotypes cooccur with some SNP genotypes at the same
loci across the samples, we obtained the matched SNP genotype data for the same sam-
ples [64] for comparison. For each latent CNV profiles (columns of matrix U) detected
by every method, we chose the top 10 most significant CNV regions and obtain the
reported SNP that overlapped with the CNV regions. In corresponding sample coeffi-
cients (rows of matrix V ), samples from the selected populations are divided into the two
groups with/without the CNV genotypes. Using the selected SNPs as features, we run
leave-one-out cross-validation with polynomial kernel Support Vector Machine classifier
to classify the two groups. The experiment is conducted for each of the K CNV geno-
types to compute the classification accuracies. To evaluate the classification accuracy,
we also repeat the classification using the same number of random consecutive SNPs
to obtain the random classification accuracy of the two sample groups with/without
the CNV genotype. The SNP features are selected from random regions containing the
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Figure 2.7: Comparison of CNV genotype callings with reported population-
differentiation CNVs from literature. (a) Comparison with 18 known population
specific CNV regions from [15,66]. For each gene, bar plot shows the mean and standard
deviation of the sample ratios of the over-represented populations across the groups
associated with the CNV profiles overlapping the region. Each region is labeled by the
gene of interest in the region or the actual genomic coordinates. (b) Comparison with
DGV database. Each black dot represents a CNV in Hapmap3 data. The x-axis is the
size of the CNVs and y-axis is the number of DGV CNV calls that overlap with the
CNV. The red circles denote the CNV calling made by treeSGS for population groups.
same number of SNPs as the background. We repeat the random experiment 100 times
to obtain the average accuracy for each of the K CNV genotype. We applied paired
t-test between the K accuracies and report the log-p-values in Figure 2.6. SLEP-GL per-
formed worst among the three methods in this measure. This is understandable because
SLEP-GL do not encourage population selection such that there is potentially higher
false-positive rate in the CNV genotype callings and thus, the groups with/without
the CNV genotypes are not supported by the SNPs in the same region. On the con-
trary, SGL tends to only detect CNV genotypes within a population such that the CNV
genotypes callings are better supported by the SNPs by losing sensitivity among the
population groups.
In Figure 2.6, varying τ leads to some variation of the classification performance
by the treeSGS-detected CNV genotypes. Overall, larger τ leads to worse performance
since the density is similar as SLEP-GL’s results. For moderate and small τ , treeSGS
method performed similarly or better than SGL. Interesting, it is not true that the more
sparser the coefficients, the better the classification results suggesting that the treeSGS
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make correct CNV callings in the selected population groups. The scatter plot of the
actual classification accuracy using the SNP features between treeSGS and the random
background is also shown in supplementary document. Generally, the classification
accuracy are about 90% on average.
2.3.4 Comparison to known population-differentiation CNVs
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Figure 2.8: Examples of improved annotation of population-differentiation
CNVs. Four CNV profiles are illustrated. In each example, the top plot shows the
overlaps between a CNV profile and the known population-differentiation CNVs with
the overlapping regions marked in red. The middle plot shows the original Hapmap3
CNV data in the overlapping regions across all the samples organized by populations.
The bottom plot shows the coefficients of the overlapped CNV profile. In all the plots,
the populations are separated by the black column bars.
We also compared the detected population(-group)-specific CNVs with two other
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studies on cross-population CNV analysis [15, 66]. The study in [66] reported 30 CNV
regions (genes) that are population differentiated among CEU, CHB+JPT, MKK and
YRI based on the analysis of SNP array data of 487 samples. There are 6 regions
overlapped with the Hapmap 3 CNV call regions. The study in [15] performed global
CNV population stratification on 236 human genomes from seven continental popula-
tion groups. Four of the populations are roughly matched with Hapmap3 populations
including AFR(African), EAS(East Asian), GIH(South Asian) and MXL(Americas).
There are 14 CNV regions overlapped between the reported extreme stratification CNVs
(Vst > 0.5) and Hapmap3 CNVs. In both studies, one of the overlapping regions occurs
in very few Hapmap3 samples and thus was removed from the analysis, which leaves 18
population-differentiation regions in total for comparison.
Figure 2.7a shows the comparison of the population specificity of the CNVs reported
by treeSGS in the 18 regions. In the comparison again each region, if the CNVs in a CNV
profile overlap with the region, the coefficients of the CNV profiles are used to classify
the samples into two groups as with/without CNV calls in the region. For each profile,
the samples with the CNV calls in the region are further divided by the differentiated
populations as suggested in the two studies. Then, across the overlapping profiles,
the mean and standard deviation of the ratio of the samples in the overrepresented
population are reported. For example, for gene SLC25A24, African population shows
more copy number than Asian populations; for gene KIAA1267, European populations
show more copy number than non-European populations. A P value is then calculated
to measure the significance of the enrichment in the suggested population. Overall, the
CNV profiles show very consistent population specifically suggested by the two studies
while both SGL and SLEP-GL did not provide comparable consistency as shown in the
supplementary document.
Database of Genomic Variants (DGV) [67] provide a comprehensive summary of
structural variation in the healthy human genome. It reported more than 300,000
CNVs from about 55,000 samples in 72 studies. Figure 2.7b shows that, among all
the 841 CNVs in Hapmap3 data, treeSGS detected CNV genotypes that overlaps with
the most frequently CNVs in DGV. The agreement supports the CNV are likely true
population-level CNV signatures.
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The recent study in [15] only reported population-differentiation CNVs from pair-
wise population comparisons. In contrast, treeSGS can detect CNVs that differentiate
between groups of populations based on the population tree. To demonstrate the dif-
ferences, we show several cases of improved annotation of population-differentiation
CNVs by treeSGS in Figure 2.8. In Figure 2.8b one of the CNV profiles (top) identi-
fied by treeSGS overlaps with 2 reported AFR-vs-AMR population-differentiation CNV
regions, one duplication region and one deletion region. However, the coefficients of
the latent CNV profile (bottom) suggest that this profile should be AFR (ASW, LWK,
MKK, YRI) population-differentiation vs all other populations. The result is clearly
supported by the original CNV data (middle) since the AFR population group show
highly frequent duplications and deletions in the two regions. Overall, it is a better
generalization that the two regions are significantly differentiated between AFR and
non-AFR, instead of only AFR vs AMR, and furthermore, these two regions co-occur
as they are in the same CNV profile. Figure 2.8a shows a CNV profile (top) overlapping
with 4 reported population-differentiation CNV deletions. Although the 4 CNVs are
annotated differently, the coefficients (bottom) suggest that this profile should be consid-
ered as differentiated between EAS+MXL+GIH and AFR, again strongly supported by
the original data (middle). Note that EUR populations is shown some major deletions
in 2 CNV regions but not all of the 4 regions, which explains why corresponding coeffi-
cients are not active for the EUR group. Figure 2.8c and 2.8d show two CNV profiles
with both coefficients reporting differentiation between non-AFR and AFR matching
well with the original data. This is clearly an improvement over the reported AFR vs
GIH/MXL/EAS population-differentiation in the original study in [15].
2.3.5 Comparison to 1000 genome project data
1000 Genomes Project creates public catalogue of human variation and genotype data.
The phase3 project collects 2504 samples’ sequencing data from 26 populations. Sim-
ilarity, the 26 populations are classified in the same 5 super populations as Hapmap3.
1000 Genome Project phase 3 data also share some samples with Hapmap3 data, with
675 samples are identical from 9 populations (no MKK, CHD populations). The vari-
ant calls of 1000 Genomes Project phase 3 data report 2974 CNV regions in autosomes,
which overlapped 220 CNV regions in Hapmap3 data (overlap with at least 2k base
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Figure 2.9: Examples of similarity on super population frequency of 1000
Genome data and treeSGS results on Hapmap3 data. two CNV regions are
shown. Left bar plot shows similarity of 1000 Genomes reported frequency and treeSGS
reported frequency on Hapmap3 data, with treeSFS reported coefficients displayed on
right plot.
pair). Among these overlapped CNVs, there are 10 CNV regions which are vary signif-
icantly in super population level (CNV frequencies of super populations have difference
greater than 0.55) and we validate these regions by checking the similarity of sample
coefficients from treeSGS results on Hapmap3 and CNV frequency in 1000 Genomes
Project phase3 data.
Figure 2.9 shows 2 examples of all 10 results. Others can be find in supplementary
material. Each figure represent a comparison on a CNV region that is reported in both
1000 Genomes Project Phase 3 data and Hapmap 3 data. In each sub-figure, the right
plot is the treeSGS coefficients of CNV profile(s) on Hapmap3 data that contains this
CNV region (marked in title). The corresponding super population ratios are shown
in the left plot as red bar. The blue bar shows the sample ratios from 1000 Genomes
Project data. The similarity of bars (correlation coefficient) is marked in bar plot title.
All 10 CNVs show a average similarity of 0.8884. This high consistency shows that
treeSGS detects CNV specificity on super population is accurate with respect to 1000
Genome sequencing data.
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2.4 Discussion
In this chapter, we propose a tree-guided group selection method, treeSGS, which us-
ing information gain theory to dynamic split tree into groups and then using group
sparse selection to identify population-differentiation CNV profiles. Experimental re-
sults clearly support that treeSGS accurately identified CNV profiles among population
groups. In the comparison with previous studies, treeSGS not only found confirmed
population-differentiation CNVs, but also improved CNV annotations with population
level differentiation.
Chapter 3
Transfer Learning Across Cancers
on DNA Copy Number Variation
Analysis
3.1 Introduction
Normally there are two copies of each gene in the human genome located on paired DNAs
in a chromosome. Large scale DNA alternations such as insertions or deletions could lead
to copy number gain or loss of the genes, which are called DNA copy number variations
(CNVs). CNVs have been found extremely common in human cancer genome [18, 19]
and it is believed that CNVs play significant roles in cancer [14, 20]. New technologies
such as array-based comparative genomic hybridization (arrayCGH) [68, 69] and SNP
genotyping arrays, are now available to measure genome-wide CNVs in high resolution at
a population scale for characterizing CNV patterns in cancer samples [6]. Identification
and systematic analysis of CNVs can provide important insights into the cellular defects
that are cancer causative and suggest potential therapeutic strategies.
Most previous computational research work focused on developing models for iden-
tifying individual CNV events from CNV samples of a single cancer type. [32] studied
17 cancer types with at least 40 samples in each cancer type and reported that about
80% somatic copy number alternations found in one cancer type can also be found in
35
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pooled analysis excluding that cancer type. The detected regions in the pooled analysis
were also found in other cancer types that are better localized. These common and
type-specific CNVs can potentially reveal unknown cancer mechanisms in the light of
cross-cancer-type analysis. However, currently there is no unified mathematical model
to simultaneously detect the CNV events common or specific to multiple cancer types
from CNV array datasets.
In this chapter, we propose a Transfer Learning with Fused Lasso model (TLFL) to
detect latent CNV components from CNV datasets of multiple cancer types, in which
each cancer type can be regarded as one domain in transfer learning. Common latent
CNV components are used as a bridge to transfer knowledge among different cancer
domains along with the domain-specific components for each cancer type to explain
the observed CNV datasets. To represent the pattern of CNV events, fused lasso is
applied on each latent CNV component to preserve the sparsity and block structure.
By using alternating optimization to solve the TLFL model, common latent features and
domain specific features could be detected from multiple domains. Compared with a
baseline method without knowledge transfer, TLFL is more robust and identifies more
accurate latent CNV components in simulations and experiments on real arrayCGH
CNV datasets and SNP genotyping array datasets.
3.2 Related Work
DNA CNVs tend to occur in continuous blocks of various sizes and thus, the adjacent
probe features are more likely to be associated in the same CNV event. Previously,
several models, such as change-point detection [70, 71], hidden Markov models [72, 73]
and Gaussian models [74,75] have been applied to address the challenge. More recently,
fused lasso model [76] which introduces `1 norm constraint to encourage sparse change
points and fused CNV features, has been found to be effective in discovering more
interpretable CNV events [77]. A fused lasso latent feature model, FLLat [29] was
proposed to take full advantage of any shared information among samples. The model
assumes each CNV sample is a linear combination of a few latent CNV components.
By factorizing the arrayCGH data matrix into the product of a coefficient matrix and
a latent feature matrix, FLLat is able to detect underlying CNV events and discern
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Figure 3.1: Outline of TLFL model. ArrayCGH or SNP genotyping array datasets
from three domains are decomposed into coefficient matrices and matrices of k latent
components. The probe locations are identical in all three datasets (m features) while
the number of samples (nA, nB and nC) can be different. The red latent components
are τ common components shared in the three domains, and the remaining components
in the same color of each dataset are k − τ domain specific components. For better
visualization, matrices in this figure are transpose from equations.
specific relationships between samples. [60] proposed a latent fused-lasso feature method
to use prior knowledge to learn group specific CNVs. Other multiple sample analysis
methods which are powerful to identify frequent individual CNVs [78–81], are neither
designed to identify CNV components nor capture the heterogeneity of samples. None
of the previous methods was specially designed as a unified mathematical formulation
to discover CNV events from multiple datasets across different cancer types.
Transfer learning uses common knowledge or structures among different domains to
enhance multiple learning tasks [48, 82]. Recently, a lot of research work on transfer
learning has been published for various learning problems such as Co-Clustering based
Classification [83], Label Propagation [84], Collaborative Dual-PLSA [85] and Matrix
Tri-Factorization based Classification [86]. The paradigm of transfer learning also fits
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the learning tasks of finding CNV components across cancer types since datasets of the
same or similar cancer types presumably bear the same or similar pathogenic cause.
However, to the best of our knowledge, no transfer learning method has been designed
for latent fused-lasso component discovery.
3.3 Method
Figure 3.1 is an outline of the TLFL model. In the Figure, each of the three cancer CNV
datasets is factorized into a product of a coefficient matrix and k latent components.
In each set of the k components, τ components are shared across the three datasets
and the remain k− τ components are specific to each dataset. The framework assumes
that the CNV features are measured on the same set of probe locations sampled from a
chromosome. Each component is learned with fused lasso on the adjacent probe features
to enforce a shape of step function to mimic true CNV signals. In the following, we
first describe the optimization formulation of the model and then introduce an alter-
nating optimization algorithm to minimize the cost function. Strategies for selecting
hyper-parameters and initialization are also suggested for the empirical practice of the
algorithm.
Table 3.1: Notations
Notation Description
δ # of domains
nd # of samples in domain d ∈ [1, δ]
m # of CNV features
k total # of components in one domain
τ # of common components
Xd data matrix of domain d, size m× nd
Uˆ matrix of common components,
size m× τ
Ud domain-specific components of
domain d, size m× (k − τ)
Vd coefficient matrix of domain d,
size k × nd
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3.3.1 Transfer Learning Framework
The notations are given in Table 3.1. Given δ datasets measured from the same m probe
locations, each dataset Xd contains nd samples from one cancer domain. The objective is
to recover k latent components [Uˆ , Ud] to reconstruct each dataset Xd with the minimal
loss of information, where Ud are k−τ latent components specific to datasetXd and Uˆ are
τ common components shared by all the datasets. Vd is the corresponding coefficient
matrix of [Uˆ , Ud] for reconstructing Xd. Specifically, the TLFL model assumes that
each sample in Xd can be represented as a linear combination of k latent components
as follows,
Xd = [Uˆ , Ud]Vd.
To obtain the k latent components [Uˆ , Ud] and coefficient matrix Vd that best reconstruct
Xd , the objective function minimizes the reconstruction error of all the datasets by a
sum of the squared loss across the datasets,
δ∑
d=1
||Xd − [Uˆ , Ud]Vd||2F .
To capture the spatial relation in the CNV probe features, each latent component (a
column in [Uˆ , Ud]) is constrained by a fused lasso. Specifically, the cost function for the
common components in Uˆ is defined as,
g(Uˆ , λC , γC)
=λC
τ∑
j=1
m∑
i=1
|Uˆ(i,j)|+ γC
τ∑
j=1
m∑
l=2
|Uˆ(l,j) − Uˆ(l−1,j)|,
(3.1)
where λC and γC ∈ R are parameters to weight the penalties and the lasso penalty is
introduced to obtain sparse CNV events in the components. Similarly, the cost function
for each domain-specific latent component is
g(Ud, λd, γd)
=λd
k−τ∑
j=1
m∑
i=1
|Ud(i,j)|+ γd
k−τ∑
j=1
m∑
l=2
|Ud(l,j) − Ud(l−1,j)|,
(3.2)
where λd and γd ∈ R are also parameters to weight the penalties. Here, λC , γC , λd and
γd for d = 1, 2, . . . , δ are hyper-parameters to be tuned (see section 3.3.3).
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Given all the cost terms introduced above, the complete objective function is defined
as
L =
δ∑
d=1
(
1
2
||Xd − [Uˆ , Ud]Vd||2F
+g(Ud, λd, γd)) + g(Uˆ , λC , γC)
s.t.
Vd ≥ 0 and Vd(i,:)V Td(i,:) = 1 for i = 1, 2, . . . , k,
(3.3)
where Vd ≥ 0 denotes the condition that each element in Vd is nonnegative and Vd(i,:) is
the ith row of Vd. This cost function combines the reconstruction errors with the lasso
and fused lasso terms weighted by λC , γC , λd and γd for d = 1, 2, . . . , δ. The nonnegative
constraints on Vd only allow positive coefficients to combine latent components which
might contain both amplification (positive) and deletion (negative) events. Each row in
every Vd is also normalized across the samples such that the learned latent components
are scaled to be comparable with each other [29]. The normalization also encourages
even contributions from every latent component features to prevent being dominated
by a few. Those considerations are meant to improve the interpretability of both the
coefficients and the components.
3.3.2 Alternating Optimization
The optimization problem in eqn 5.1 can be solved by alternating updates to the vari-
ables Uˆ , Ud and Vd iteratively. Specifically, we solve subproblems on only one group of
variables by fixing the other two and alternate through the three groups of variables in
each iteration. The alternating procedure is repeated until convergence. The detailed
TLFL algorithm is described in Algorithm 4. Below we outline the solution to each
subproblem to solve for Uˆ , Ud and Vd, respectively.
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Algorithm 4 TLFL
Input: {Xd}δd=1, k, τ , {γd}δd=1,{λd}δd=1, γC , λC
Output: Uˆ , {Ud}δd=1, {Vd}δd=1
1: initialize Uˆ , {Ud}δd=1
2: repeat
3: for d = 1, . . . , δ do
4: for j = 1, . . . , nd do
5: solve arg minVd(:,j) ||Xd(:,j) − [Uˆ , Ud]Vd(:,j)||2F
6: s.t. Vd(:,j) ≥ 0 (eqn 3.5)
7: end for
8: normalize Vd s.t. Vd(i,:) × V Td(i,:) = 1 for i = 1, 2, . . . , k
9: X˙d = Xd − UˆVd(1:τ,:)
10: solve arg minUd(
1
2 ||X˙d − UdVd(τ+1:k,:)||2F + g(Ud, γd, λd)) (eqn 3.6)
11: end for
12: for d = 1, . . . , δ do
13: X¨d = Xd − UdVd(τ+1:k,:)
14: end for
15: Xall = [X¨1, X¨2, . . . , X¨δ]
16: Vall = [V1(1:τ,:), V2(1:τ,:), . . . , Vδ(1:τ,:)]
17: solve arg minUˆ (
1
2 ||Xall − UˆVall||2F + g(Uˆ , γC , λC)) (eqn 3.7)
18: until Uˆ , {Ud}δd=1, {Vd}δd=1 converge
Updating coefficient matrix Vd
When Uˆ and Ud are fixed, eqn 5.1 is only a function on Vd simplified as
arg min
Vd
||Xd − [Uˆ , Ud]Vd||2F
s.t.
Vd ≥ 0 and Vd(i,:)V Td(i,:) = 1 for i = 1, 2, . . . , k.
(3.4)
For each column Xd(:,j), we can solve a nonnegative least-square problem to obtain a
solution for Vd(:,j).
arg min
Vd(:,j)
||Xd(:,j) − [Uˆ , Ud]Vd(:,j)||2F
s.t.
Vd(:,j) ≥ 0.
(3.5)
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Then Vd can be normalized as Vd(i,:)V
T
d(i,:) = 1 for i = 1, 2, . . . , k.
Updating domain-specific components Ud
When Uˆ and Vd are fixed, eqn 5.1 is only a function on Ud simplified as
1
2
||Xd − [Uˆ , Ud]Vd||2F + g(Ud, γd, λd)
=
1
2
||X˙d − UdVd(τ+1:k,:)||2F + g(Ud, γd, λd),
(3.6)
where residue X˙d is defined as
X˙d ≡ Xd − UˆVd(1:τ,:).
This problem is equivalent to the general fused lasso problem, which can be solved by
the SLEP package [87].
Updating common components Uˆ
When Ud and Vd are fixed, eqn 5.1 is only a function on Uˆ simplified as
δ∑
d=1
(
1
2
||Xd − [Uˆ , Ud]Vd||2F ) + g(Uˆ , γC , λC)
=
1
2
||Xall − UˆVall||2F + g(Uˆ , γC , λC),
(3.7)
where we define
X¨d ≡ Xd − UdVd(τ+1:k,:),
Xall ≡ [X¨1, X¨2, . . . , X¨δ],
Vall ≡ [V1(1:τ,:), V2(1:τ,:), . . . , Vδ(1:τ,:)].
Similarly, this problem is also equivalent to the general fused lasso problem, which can
be solved by the SLEP package.
3.3.3 Initialization and Hyper-parameter Selection
Since eqn 5.1 is not convex, alternating updates in TLFL do not guarantee a global
optimal solution. The local optimal solution heavily relies on proper initialization of
Uˆ and Ud. We adopt a simple strategy to choose the initialization. We use Principle
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Component Analysis (PCA) on pooled data [X1, X2, . . . , Xδ] to select top τ components
as the initialization of common components Uˆ . For domain specific components, PCA
is applied on each domain data separately to select the top k components for each
domain. Then, the top τ components of the k components of each domain that are
most similar to the initialization of Uˆ are removed. The similarity is measured by the
absolute correlation coefficients. For each domain, the remaining k− τ components are
used as the initialization of domain specific components Ud.
The number of latent component k was chosen as the number of principle components
that can explain α ∈ [0, 1] variation of the arrayCGH or SNP genotyping array datasets.
For multiple domains, the calculated k could vary among the datasets. We simply choose
the maximal as a global k to explain at least α variance in each dataset. A user also
needs to select a parameter β ≡ τ/k to control the ratio between common component
number τ and total component number k. For similar datasets such as datasets of the
same or closely related cancer types, β should be chosen larger while for datasets from
different cancer types, β should be chosen smaller. Presumably, β could be determined
by a user’s perception of the similarity across the domains.
Parameters λC , γC , λd and γd are chosen by the same Bayesian Information Criterion
(BIC) introduced in [29]. BIC controls both model complexity and training error to
avoid overfitting. For each domain, λd and γd are selected with dataset Xd and k
components. λC and γC are selected with the combined dataset [X1, X2, . . . , Xδ] and
τ + δ ∗ (k − τ) components. Note that we could apply BIC to the complete model in
eqn 5.1 to jointly select λC , γC , λd and γd. However, jointly choosing four parameters
is not scalable even on datasets of moderate size. Thus, we divided the estimation into
smaller BIC problems as described above.
3.4 Simulation
In the section, we generated artificial datasets to test TLFL model in three measure-
ments: 1) performance of recovering latent components; 2) performance of detecting
hidden sample group structures in coefficient matrix for classification and clustering;
and 3) convergence and robustness under different noise levels and ratios between
common and domain-specific components. The synthetic datasets are constructed as
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Figure 3.2: Performance of latent component detection by TLFL, pool FLLat (P FLLat)
and split FLLat (S FLLat) section 3.4.1. The box-plots are computed from 10 random
experiments. D1, D2 and D3 denote the three domains.
Xd = [Uˆ , Ud] ∗ Vd + Ξ, where latent component matrix [Uˆ , Ud] and coefficient matrix
Vd are either predefined or randomly generated, and the entries in Ξ are IID gaussian
noises. In all simulations, the hyper-parameters λ and γ are selected as described in
section 3.3.3, and k and τ are assumed known. In each component in [Uˆ , Ud], 4 in-
dependent copy number gain or loss events were assumed and randomly located with
magnitudes in [−1, 1] over 2000 probe features. The components are not strictly or-
thogonal but the correlation between any two components is required to be smaller
than 0.3. The entries in Vd are random nonnegative values in [0, 1] and normalized
as Vd(i,:)V
T
d(i,:) = 1, i = 1, 2, . . . , k. We compared TLFL with FLLat [29] to show the
advantage of transfer learning and discrimination of common and domain specific com-
ponents. In each experiment, TLFL is applied jointly on three datasets. FLLat was
applied on 1) a pooled dataset of all the domain datasets (pool FLLat) and 2) each
domain dataset individually (split FLLat).
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Figure 3.3: Latent components detected by TLFL and FLLat are compared with the
known true components. The rows represent the common components and the compo-
nents specific to the domains (D1, D2 and D3). The columns from left to right represent
true components, components detected by TLFL, components detected by pool FLLat,
and components detected by split FLLat for D1, D2 and D3 with one column for each
domain.
3.4.1 Recovering Latent CNV Components
Three synthetic datasets of sample size 300, 420 and 510 respectively were generated.
In all the datasets, there are 7 latent components, 5 of which are common compo-
nents Uˆ and 2 are domain-specific components Ud for each dataset, Note that no
structure is assumed in the coefficient matrices Vd in this simulation. Gaussian noises
Ξ ∼ (µ = 0, σ = 0.3) were added. In this simulation, we focused on recovering the
known latent components used to generate the synthetic datasets with added noise.
The performance is measured by the average Pearson correlation coefficients of each
estimated latent component with its corresponding known component. Since FLLat
allows negative coefficients, some latent components were negated to obtain the best
correlation coefficients with the known components. With the components were fixed,
randomized coefficient matrices and noise were generated for 10 trials.
The performance of TLFL, split FLLat and pool FLLat for recovering the known
components is shown in Figure 3.2. TLFL outperformed both split and pool FLLat
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in each domain under the comparison across either common components or domain-
specific components. Interestingly, TLFL tends to identify more consistent common
components than the FLLat models in the 10 repeats with smaller variance. Paired-
sample t-test of the component correlations by TLFL and FLLat for common compo-
nents, domain-specific components and all components are all significant with the largest
p− value = 4.46E− 04, which indicates that TLFL significantly outperforms both split
and pool FLLat in detecting the known latent CNV components. To illustrate the detect
components, Figure 3.3 shows the side-by-side comparison of each component detected
by FLTL, split FLLat or pool FLLat with the known component from one trial. In this
example, pool FLLat failed to detect the third common component and split FLLat
detected no signal correlating with the second common component in all three domains
while TLFL captured all the true events accurately. In the fifth common component,
both FLLat methods failed to separate the signal from the other components. Similar
advantages by TLFL are also seen in the comparison of domain-specific components.
3.4.2 Sample Classification by Coefficient Matrices
Under the assumption that the latent components are underlying features describing
tumor characteristics, the coefficient matrices are presumably informative for patient
classification or clustering. For example, some latent features might represent CNV
aberrations disrupting a gene pathway in a certain tumor stage, and thus samples with
a large coefficient on the latent features are more likely to be associated with that
particular tumor stage. Therefore, in this simulation we focused on using the learned
coefficient matrices for sample classification and clustering.
Similarly, three synthetic datasets of sample size 300, 420 and 510 respectively were
generated with 5 common latent components and 2 domain specific components in each
domain. To create patient classes (clusters), we designed coefficient matrices represent-
ing patterns of three classes (patient subgroups) in each domain as shown in Figure 3.4.
The true coefficient matrices shown at row 2 in Figure 3.4 are constructed by adding
gaussian noise on the structured seed matrices at row 1. The coefficient matrices were
then multiplied with components similarly generated as in section 3.4.1 and added with
gaussian noises Ξ ∼ (µ = 0, σ = 0.3) to get the synthetic datasets. With the latent
components and structure seeds fixed, we repeated the simulation procedure 10 times
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Figure 3.4: Comparison of learned coefficient matrices (components by samples). The
plots are shown for row 1: structured seed matrices; row 2: true coefficient matrices
constructed by adding noise to the structured seed matrices; row 3: coefficient matrices
learned by TLFL; and row 4: coefficient matrices learned by split FLLat. Three classes
of equal sizes are assumed in each domain.
under the gaussian noises.
The last two rows of matrices in Figure 3.4 show the coefficient matrices learned by
TLFL and split FLLat in one trial. In this visualization, it is clear that split FLLat
made mistakes in several places such as zero coefficient of the first component in domain
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Figure 3.5: Classification and clustering performance on coefficient matrices learned by
TLFL, pool FLLat and split FLLat. The comparisons are between the methods on the
three domains (D1, D2 and D3) in 10 random trials.
1 and domain 2, and the fifth component on domain 3. The overall structure of the
coefficient matrices in not as distinguishable as those detected by TLFL. Since pool
FLLat learned a different number features (number of rows in Vd), it is not directly
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Figure 3.6: Components detection performance comparison between TLFL and
pool/split FLLat under different noise levels.
comparable in Figure 3.4 .
To better measure the accuracy of the coefficients, classification and clustering of
samples were performed on the learned coefficient matrices. The leave-one-out cross-
validation with linear SVM classifier was performed for classification of the samples.
K-means clustering (K=3) was applied to cluster the samples. For K-means clustering,
the averages of 100 runs are reported for each domain in each trial. Figure 3.5 shows
the comparison of the classification and clustering results by TLFL and FLLat (pool
and split) by scatter plots. In both classification and clustering comparisons, almost all
the cases are well above the diagonal line, i.e. TLFL performed better than FLLat by
a large margin. In addition, TLFL also detected better components in this simulation
(results not shown).
3.4.3 Robustness and Convergence
To understand the robustness of TLFL and FLLat under the presence of different noise
level, we tested datasets with varying amount of added noise in this simulation. Three
domain datasets of sizes 60, 75 and 90 respectively were generated with 5 common
components and 2 domain specific components in each domain. The gaussian noises
were drew from (µ = 0, σ) with σ ranging from 0 to 1 with 0.1 step. To test each noise
level, the simulations were repeated 10 times. Figure 3.6 shows that the performance
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Figure 3.7: Effect of varying the number of common components. The errorbars show
TLFL performance under different τ with fixed datasets. Note that when τ = 0, TLFL
is equivalent to split FLLat and when τ = 8, TLFL is equivalent to pool FLLat.
of component detection drops as the noise level increases for both TLFL and FLLat.
TLFL performs consistently better than both pool FLLat and split FLLat when the
noise level is reasonable (≤ 0.5) with the benefit of transfer learning. TLFL and FLLat
performs similarly due to the extremely high noise level that almost completely blurred
the original signals. And at this noise level the accuracy of the learn components is very
low.
In most of the real cases, the best ratio of τ and k is unknown. It is thus interesting
to understand the performance of TLFL when τ varies. Intuitively, τ is directly related
to how much knowledge to transfer across the different domains. The more similar the
domains, the larger τ desired. In the two extremes, when τ = 0 TLFL is equivalent to
split FLLat, and when τ = k TLFL is equivalent to pool FLLat. We generated synthetic
datasets of sample size 150, 180 and 210, each with 600 features and 8 latent components
in each domain, 4 of which are common components. Similarly, we fixed the components
and generated coefficient matrices randomly with gaussian noises Ξ ∼ (µ = 0, σ = 0.3)
added in 10 trials for each choice of τ ∈ [1, 2, . . . , 7]. The results of 10 trials is shown in
Figure 3.7. It is clear that when τ = 4 or 5, which is close to the true τ , TLFL performs
the best.
Figure 3.8 shows one example of convergency in running the TLFL algorithm. TLFL
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Figure 3.8: Convergence of TLFL for one run from section 3.4.1. After around 60
iteration, components and coefficient matrices are converged.
convergences fast within lower tens of iterations. Most of the simulations aforementioned
converged less within 100 times regardless of the sample sizes.
3.5 Experiments on Cancer Datasets
We performed two experiments on real cancer CNV datasets. The first experiment is
a cross-dataset analysis on bladder cancer to show that TLFL can utilize information
from other similar datasets to improve classification. The second experiment is a cross-
domain analysis on breast cancer and ovarian cancer.
3.5.1 Analysis Across Bladder Cancer Datasets
TLFL, split FLLat and pool FLLat were tested on two bladder cancer arrayCGH
datasets: Blaveri05 [88] and Stansky06 [89]. Both datasets contain urothelial carci-
nomas with whole-genome tiling resolution arrayCGH and high density expression pro-
filing. There are 98 samples in Blaveri05 dataset and 57 in Stansky06. Since the two
datasets were not measured by the same resolution, we interpolated the datasets in
whole genome to obtain CNV readings at the same probe positions with a resolution
of 500k bps per probe. All the samples from the two arrayCGH datasets are provided
with information on tumor stage. In Blaveri05 dataset, the stages are Ta, T1, T2, T3
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and T4, and in Stransky06 dataset, the stages are Ta, T1a, T1b, T2, T3a, T3b, T4a
and T4b. We relabel the stages into 3 classes for each dataset: Blaveri05 with stages
({Ta}, {T1, T2}, {T3, T4}) and Stransky05 with stages ({Ta},{T1a, T1b, T2},{T3a,
T3b, T4a, T4b}), ordered from less severe stage to more advanced stage.
For each chromosome in the two datasets, the number of latent components was
chosen as the number of principle components that could explain at least 80% variance
of the data. The parameter k for a certain chromosome was then set as the larger number
of principle components of the two datasets. Since both datasets are on similar bladder
carcinomas, we assume a large fraction of common components. For each chromosome,
we took the ratio of τ/k as 70%. Parameters λ1, γ1, λ2, γ2, λC and γC were calculated by
BIC as described in section 3.3.3. Table 3.2 reports the leave-one-out SVM classification
results of the three classes using the coefficient matrices learned by TLFL, split FLLat
and pool FLLat. Among the tests on all 22 chromosomes, 11 tests of Stransky06 and
10 tests of Blaveri05 present the best classification results by TLFL than both FLLat
methods (numbers with color red) while on two chromosomes of Stransky06 dataset and
7 of Blaveri05 dataset, TLFL performed worse classification than both FLLat methods
(numbers with color blue). Overall improvement is observed on both datasets for the
average classification results of the 22 chromosomes.
Table 3.2: Classification of bladder cancer datasets.
Chr
Stransky06 Blaveri05 Average
TLFL pool FLLat split FLLat TLFL pool FLLat split FLLat TLFL pool FLLat split FLLat
1 0.4795 0.4444 0.4386 0.5748 0.5714 0.5782 0.5272 0.5079 0.5084
2 0.4912 0.4737 0.4737 0.6361 0.6224 0.6361 0.5636 0.5481 0.5549
3 0.5906 0.5614 0.5029 0.6429 0.6429 0.6599 0.6168 0.6021 0.5814
4 0.6608 0.5848 0.6082 0.5544 0.5578 0.5544 0.6076 0.5713 0.5813
5 0.5439 0.5088 0.5263 0.6565 0.6565 0.6429 0.6002 0.5826 0.5846
6 0.5731 0.5556 0.5556 0.5884 0.6190 0.5918 0.5808 0.5873 0.5737
7 0.5906 0.6667 0.6374 0.6633 0.6395 0.6361 0.6270 0.6531 0.6367
8 0.6199 0.6316 0.6140 0.5952 0.5986 0.5714 0.6076 0.6151 0.5927
9 0.6140 0.6082 0.5146 0.6020 0.6224 0.6156 0.6080 0.6153 0.5651
10 0.6023 0.6316 0.5322 0.5850 0.5748 0.5748 0.5937 0.6032 0.5535
11 0.6140 0.6082 0.6023 0.6088 0.6395 0.6361 0.6114 0.6238 0.6192
12 0.5848 0.5556 0.5380 0.6020 0.5748 0.5748 0.5934 0.5652 0.5564
13 0.5439 0.5205 0.5673 0.5952 0.5816 0.5952 0.5695 0.5511 0.5812
14 0.5848 0.6433 0.5789 0.5680 0.5816 0.5918 0.5764 0.6125 0.5854
15 0.4737 0.4444 0.4795 0.6293 0.6190 0.5918 0.5515 0.5317 0.5357
16 0.6433 0.6491 0.6316 0.5782 0.6122 0.5884 0.6108 0.6307 0.6100
17 0.5205 0.6257 0.5322 0.5000 0.5034 0.5646 0.5102 0.5646 0.5484
18 0.5380 0.5322 0.4971 0.6224 0.6122 0.6054 0.5802 0.5722 0.5513
19 0.5322 0.5146 0.5789 0.5850 0.6122 0.6054 0.5586 0.5634 0.5922
20 0.6550 0.6667 0.6491 0.5986 0.6020 0.5918 0.6268 0.6344 0.6205
21 0.4561 0.4795 0.4561 0.5374 0.5136 0.5238 0.4968 0.4966 0.4900
22 0.5673 0.5380 0.4678 0.5782 0.5136 0.5340 0.5727 0.5258 0.5009
ave 0.5673 0.5657 0.5447 0.5955 0.5942 0.5938 0.5814 0.5799 0.5693
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3.5.2 Analysis Across Cancer Domains
We applied TLFL method on two related cancer types, breast cancer and ovarian cancer,
to detect common CNV patterns. The two CNV datasets were downloaded from TCGA
data-portal1 SNP level 2 tangent data, generated from Affymetrix Genome-Wide
Human SNP Array 6.0 platform. To label the patients for survival prediction, we chose
breast cancer patient samples that had a survival time less than 5 years as the positive
group and longer than 8 years as the negative group. Similarly, we chose the ovarian
cancer patients with survival time less 1 year as positive samples and longer than 5
years as negative samples. With this criteria, 103 breast cancer samples (56 positive
and 47 negative) and 124 ovarian cancer samples (46 positive and 78 negative) were
selected. To reduce the computational load, we sampled data with 150k bp per probe
resolution. Based on the genetic relevance of breast cancer and ovarian cancer described
in OMIM, we focused on chromosomes 3, 8, 10, 13 and 17 in this analysis. The number
of components were chosen to explain between 60%-75% of variance in each chromosome
respectively. Since these are two different but related cancer types, we took a smaller
ratio of τ/k as 60%.
Similarly, leave-one-out classification was performed on the coefficient matrices learned
by TLFL, pool FLLat and split FLLat. The results are shown in Table 3.3. TLFL per-
formed similar classification to FLLat on chromosome 3 and 8 but better on the other
chromosomes and overall average of both the breast cancer and ovarian cancer datasets.
To detect more focal CNV events (short CNV regions), we increased the hyper-
parameter of common components γC and λC by multiplying a factor 2.5 and reran
TLFL on both datasets. The common CNVs between breast cancer and ovarian cancer
detected by TLFL are shown in Figure 3.9. Eighteen known cancer genes locate in these
very focal CNV regions. thirteen among the eighteen genes (except CCDC6, FAM22A,
ZMYM2 and SRSF2. GATA3 is found only related with breast cancer) were reported
to play a role in both breast cancer and ovarian cancer as reported by details in Table
3.4. For example, deletion or hyper-methylation of tumor suppressor FHIT leads to high
proliferation of both breast cancer and ovarian cancer [90–93]; and BRIP1 interacts with
BRCA1 and its variants are candidates of breast and ovarian cancer susceptibility [94].
1 https://tcga-data.nci.nih.gov/.
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The extensive literature supports that those common CNVs might play an important
role in both breast and ovarian cancer.
Table 3.3: Classification of breast and ovarian cancer datasets.
Chr
Breast cancer Ovarian cancer Average
TLFL pool FLLat split FLLat TLFL pool FLLat split FLLat TLFL pool FLLat split FLLat
3 0.5777 0.5922 0.5971 0.5363 0.6048 0.5040 0.5570 0.5985 0.5506
8 0.4466 0.4223 0.4612 0.4234 0.4153 0.5081 0.4350 0.4188 0.4846
10 0.6553 0.5194 0.5922 0.4758 0.3992 0.4516 0.5656 0.4593 0.5219
13 0.5194 0.4951 0.4612 0.5887 0.5887 0.5847 0.5541 0.5419 0.5229
17 0.5291 0.5049 0.5194 0.5766 0.5645 0.5323 0.5529 0.5347 0.5258
ave 0.5456 0.5068 0.5262 0.5202 0.5145 0.5161 0.5329 0.5107 0.5212
3.6 Conclusions
Application of transfer learning to CNV analysis across multiple cancer types is promis-
ing since CNVs are a hallmark of cancer genomes. To the best of our knowledge, TLFL
is the first transfer learning method to utilize multiple cancer domains for detecting
common and domain-specific CNVs as fused latent components. The transfer learning
enables sharing information in datasets of different cancer domains to discover latent
CNV features that can explain common and domain-specific cancer characteristics and
better classify patient samples as shown in the experiments. In the recent TCGA (The
Cancer Genome Atlas) initiative, more and more CNV datasets are becoming available
for 21 types of cancer. It is expected that transfer learning will play an important role in
the comparative analysis of the large patient cohorts to improve the current knowledge
of cancer development and progression in the light of both common and specific cancer
CNVs.
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Table 3.4: Cancer genes in common components
Gene Association with breast cancer and ovarian cancer Hyperlink to reference
MLH1 Loss of MLH1 plays a role in drug resistance in breast cancer; methylation of the
hMLH1 promoter is possibly related to cisplatin-resistance in ovarian cancer.
Mackay, H. J., et al.
Samimi, Goli, et al.
Strathdee, G., et al.
FHIT Deletion or hyper-methylation of tumor suppressor FHIT leads to high prolifer-
ation of both breast cancer and ovarian cancer.
Fullwood, P., et al.
Dhillon, V.S., et al.
Campiglio, M., et al.
Zochbauer-Muller, S., et al.
TFRC TFRC together with ACTB are used for breast cancer quantification; TFRC
expresses differently between normal and poorly differentiated serous papillary
adenocarcinoma (PD-SPA) of the ovary.
Majidzadeh-A, K., et al.
Martoglio, A. M., et al.
BMPR1A BMPR1A highly expresses in breast cancer and ovarian cancer. Alarmo, E. L., et al.
Shepherd, T. G., et al.
Bowen, N. J., et al.
CCDC6 Lack of evidence
FAM22A Lack of evidence
FGFR2 Four SNPs of FGFR2 are confirmed highly associated with breast cancer and
FGFR2 expresses increasingly in the rare homozygotes; combining FGFR2 in-
hibitors with platinum-containing cytotoxic agents for the treatment of epithelial
ovarian cancer may yield increased anti-tumor activity.
Hunter, D. J., et al.
Meyer, K. B., et al.
Cole, C., et al.
GATA3 Low GATA3 expression is associated with higher histologic grade and short sur-
vival time in breast cancer; No direct evidence to show relation between GATA3
with ovarian cancer.
Mehra, R., et al.
Hoch, R. V., et al.
MYST4 MYST4 is up-regulated in ER-positive breast cancer cells and ovarian cancer
cells.
Kok, M., et al.
Vignati, S., et al.
PTEN PTEN may suppress tumor cell growth and regulate tumor cell invasion and
metastasis through interactions at focal adhesions in breast cancer; PTEN mu-
tations are frequent in endometrioid ovarian tumors.
Li, J., et al.
Obata, K., et al.
FAS FAS is a reliable prognostic marker to predict DFS and OS in patients with early
breast cancer; Decreased sensitivity to Fas-mediated apoptosis could contribute
to ovarian tumorigenesis and may play a role in ovarian tumorigenesis.
Alo, P. L., et al.
Baldwin, R. L., et al.
Meinhold-Heerlein, I., et al.
RB1 RB1 is most likely involved in the development of breast cancer; Two SNPs of
RB1 showed significant association with ovarian cancer risk.
Spandidos, D. A., et al.
Song, H., et al.
ZMYM2 Lack of evidence
BRCA1 The 17q-linked BRCA1 gene is identified to have influences susceptibility to
breast and ovarian cancer.
Ford, D., et al.
Miki, Y., et al.
BRIP1 BRIP1 interacts with BRCA1 and its variants are candidates of breast and ovar-
ian cancer susceptibility.
Song, H., et al.
SEPT9 Increased SEPT9 v1 expression contributes to the malignant pathogenesis of
some breast tumors; Experiment shows consistent and specific overexpression of
both SEPT9 v1 and SEPT9 v4 transcripts in the epithelial component of ovarian
tumors.
Gonzalez, M. E., et al.
Scott, M., et al.
SRSF2 Lack of evidence
YWHAE Expression level upregulated gene YWHAE together with other 5 genes show a
significant association to both disease-free and overall survival in breast cancer;
YWHAE is identified from the TOV-112D ovarian cancer cell line.
Cimino, D., et al.
Gagne´ J. P., et al.
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Figure 3.9: Common CNV events in breast cancer and ovarian cancer with co-located
cancer genes annotated. Amplification (red) and deletion (blue) CNV events are plot
along the selected chromosomes.
Chapter 4
Multitask Clustering of
scRNA-seq Data
4.1 Introduction
Single-cell RNA sequencing (scRNA-seq) technology has emerged as a promising genome-
wide mRNA expression quantification method in individual cells. Traditional bulk RNA-
seq ignores the cell differences in a cell population and treats all cells as homogeneous.
Furthermore, genes with low expression values may be undetectable in bulk RNA-seq
since they may only be expressed in a small number of uncommon or transient cell types.
To overcome these limitations, scRNA-seq identifies cell types by sub-populations of sin-
gle cells to characterize sub-population structure and to understand disease progression
and mechanisms of transcription regulation [25].
As a new technology, there are unique challenges in scRNA-seq experiments and
data analysis. A typical scRNA-seq protocol is as follows: isolation of single cells
and RNA, reverse transcription, amplification, library generation, and sequencing. In
each step, technical noise and biases are introduced [11]. In addition to the noise
and bias that also exist in bulk RNA-seq experiments, issues unique to scRNA-seq
include those from biological sources, such as cell-cycle stage or cell size, as well as from
technical/systematic sources, such as capture inefficiency, material degradation, sample
contamination, amplification biases, GC content, and sequencing depth. For example,
due to the tiny amount of starting material [26], heavy PCR amplification is needed
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Figure 4.1: Strategies of clustering multiple single-cell populations.. In the
example, four cell types are shown in four different colors. Ground Truth: 2D plot
of a pool of single cells by the true marker genes A and B combined from 3 single-cell
populations of identical distributions. Simulated Single-cell Populations: 3D plots
of the three single-cell populations separated by marker genes A, B and non-marker
gene X. The simulation data are generated from the ground truth data with rotation
and scaling to represent technical biases and biological variation with an additional
997 random genes (1000 genes in total) added to each experiment. Additional noise
is also introduced. Three different clustering strategies are shown below. Pooled
Clustering: 2D plot on the true marker genes A and B on pooled data that simply
combines 3 single-cell populations together for clustering. Even with the correct marker
selection, cells from different types are still mixed because of the rotations and scaling.
Separated Clustering: 2D plot on each individual cell population. With the limited
single-cell sample size and skewed cell-type distribution, incorrect marker genes may
be selected, shown as genes P, Q and R. Multitask Clustering and Embedded
Feature Selection: Our proposed method can identify both the true marker genes
and cluster the cell types in each population with a multitask learning strategy. The
clustering of each dataset is reinforced from the results in the other two datasets shown
as the connected clusters across the three experiments.
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before sequencing. Biases introduced by PCR are exponentially amplified. Alternative
amplification techniques, such as in vitro transcription also suffer from transcription
inefficiency and sequence drop-out. These biases and noise cause uneven coverage of
the entire transcriptome and result in an abundance of zero-coverage regions [28].
In this chapter, we introduce a multitask learning method with an embedded feature
selection to capture most the differentially expressed genes among cell clusters across all
cell populations to achieve better single-cell clustering simultaneously. The key to doing
this is the use of multiple single-cell populations available from biological replicates or
related samples with significant biological variances such as samples cultured indepen-
dently or obtained from different patients. To illustrate the objective, Figure 4.1 shows
an example of scRNA-seq data of 100 single cells from three cell populations (n = 33,
33 and 34) with 1000 genes expressed. Of the 1000 genes, genes A and gene B are the
hidden markers that are differentially expressed across the four cell types (indicated by
the four different colors). In the ideal scenario, there is no technical bias and the marker
genes are known as shown in the “Ground Truth” in Figure 4.1. ”Simulated Single-cell
Populations” in Figure 4.1 shows the single-cell datasets after biological variation, tech-
nical biases, and noise are introduced, The data distribution is very different across the
three cell populations after the rotation, re-scaling and addition of noise. This makes it
challenging to identify the true marker genes with a limited number of samples in each
population. Simply pooling the single-cell data from the three populations together will
confuse the clustering, even with the correct marker genes identified in ”Pooled Cluster-
ing”; separated clustering on each single-cell population suffers more from the biological
variation as the number of single cells are not sufficient in each individual analysis
to identify the true maker genes in ”Separated Clustering”. We propose a variance-
driven multitask clustering of single-cell RNA-seq data (scVDMC) algorithm, as shown
in ”Multitask Clustering and Embedded Feature Selection” in Figure 4.1, that utilizes
expression patterns of different single-cell populations with shared cell-type markers for
better integration.
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4.2 Method
In this section, we first introduce the model and the algorithm of variance-driven mul-
titask clustering of single cells (scVDMC) and then discuss the parameter selection for
scVDMC and related work in single-cell RNA-seq clustering.
4.2.1 A multitask clustering and feature selection model
Assume a total of D domains with each domain representing a single-cell population
for clustering. Let matrix X(d) ∈ Rm×n(d) denote RNA-seq gene expression values from
domain d, where m is the number of features (genes) and n(d) is the single-cell sample
size of domain d, d = 1, 2, . . . , D. Let U (d) ∈ Rm×k denote the cell-type cluster centers
and the binary matrix V (d) ∈ Zn(d)×k2 denote the assignments of each single-cell to the
clusters, where k is the number of cell types (clusters) and Z2 = {0, 1}. With the binary
vector B ∈ Zm×12 denoting the indicators of feature selection (1: selected and 0: not
selected) and DB denoting the diagonal matrix with B on the diagonal, scVDMC model
is defined as:
minimize
U(d),V (d),B
1
2
D∑
d=1
||DB(X(d) − U (d)V (d)T )||2F
−w
D∑
d=1
BTVar(U (d))
subject to
∑
B = λ,∑
j
V
(d)
i,j = 1,
∀i = 1, 2, . . . , n(d), ∀d = 1, 2, . . . , D
(4.1)
where w > 0 is a hyper-parameter to balance the two error terms, the reconstruction
error, and the cluster center separation, and λ ∈ Z+ is the predefined number of features
to be selected.
In the model in equation (4.1), ||X(d)−U (d)V (d)T ||2F denotes the reconstruction error
of the classic k-means clustering as matrix factorization. Since only a small number of
genes are expected as the markers differentiating the cell types, the model restricts the
reconstruction error as ||DB(X(d) − U (d)V (d)T )||2F , where DB only selects the errors on
the selected markers by B. The second term BTVar(U (d)) is introduced to maximize
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the separation of the cluster centers, where Var(U (d)) is defined as a vector where each
element is the variance of the vector U
(d)
i,: ∈ Rk×1 [95]. Note that the reconstruction
error encourages selection of low expression genes since the errors are smaller on smaller
numbers and the second variance terms encourages selection of high expression genes
since the variances are larger on larger numbers. Together as the sum over all the
domains, the cost function provides a balanced error on the compactness and separation
of the clusters of the cell types tuned by feature selection across all the domains. The
unique cluster centers in each domain preserves the unique expression patterns while
the features are selected as common marker genes for different cell types. For the two
hyper-parameters in equation (4.1), λ (the number of marker genes) is typically a small
number based on prior knowledge of the cell types, and the selection of balancing weight
w is discussed in section 4.2.3.
4.2.2 Alternating updating algorithm
Algorithm 5 scVDMC algorithm
1: Input: X(d), k, w, λ, d = 1, 2, . . . , D
2: output: U (d), V (d), B
3: Initialize U (d) and V (d).
4: repeat
5: compute B with linear programming in equation (4.7)
6: for d = 1, 2, . . . , D do
7: solve V (d) by equation (4.2)
8: repeat: split the largest cluster if there is an empty cluster
9: solve U (d) by (4.6)
10: end for
11: until U (d), V (d) and B converge
12: return U (d), V (d) and B
The goal is to minimize the cost function in equation (4.1) to obtain the optimal
U (d), V (d) and B. We employ an alternating update strategy to solve the optimization
problem. First, we fix the feature selection B, all the cluster centers U (d) and all other
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V (d) to obtain a certain V (d).
minimize
V (d)
1
2
||DB(X(d) − U (d)V (d)T )||2F
subject to
∑
j
V
(d)
i,j = 1, ∀i = 1, 2, . . . , n(d).
(4.2)
This is equivalent to assigning samples to the nearest centers U (d) by the Euclidean
distance in the features selected by B, where each column of DBX
(d) is a sample and
each column of DBU
(d) is a center. Then the distance of a sample to every center is
calculated and the nearest center is chosen to assign 1 to the corresponding V (d).
Next, we fix the feature selection B, all clustering assignments V (d), and all other
U (d) to solve a certain U (d), rewritten as:
minimize
U(d)
1
2
m∑
i=1
Bi||(X(d)i,: − U (d)i,: V (d)
T
)||22 − w
m∑
i=1
BiVar(U
(d)
i,: ), (4.3)
where Var(U
(d)
i,: ) is the variance of vector U
(d)
i,: which is defined as
Var(U
(d)
i,: ) =
1
k
(U
(d)
i,: −
U
(d)
i,: 11
T
k
)(U
(d)
i,: −
U
(d)
i,: 11
T
k
)T
=
1
k
U
(d)
i,: (I−
11T
k
)(I− 11
T
k
)TU
(d)
i,:
T
=
1
k
U
(d)
i,: (I−
11T
k
)U
(d)
i,:
T
,
(4.4)
where I denotes the identity matrix and 1 is a column vector of all ones. LetM ≡ I−11Tk .
Then equation (4.3) can be rewritten as:
minimize
U(d)
1
2
m∑
i=1
BiU
(d)
i,:
T
(V (d)
T
V (d) − 2wM
k
)U
(d)
i,:
−
m∑
i=1
BiX
(d)
i,: V
(d)U
(d)
i,:
T
+
1
2
m∑
i=1
BiX
(d)
i,: X
(d)
i,:
T
.
(4.5)
When w is properly chosen (see section 4.2.3), equation (4.5) is convex and the
closed-form solution is
U
(d)
i,:
T
= (V (d)
T
V (d) − 2wM
k
)−1V (d)
T
X
(d)
i,:
T
. (4.6)
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Finally, to update binary vector B, we fix all U (d) and V (d) to optimize
minimize
B
m∑
i=1
Bi
D∑
d=1
(
1
2
||(X(d)i,: − U (d)i,: V (d)
T
)||22 − wVar(U (d)i,: ))
subject to
∑
B = λ,
(4.7)
which is a standard constrained linear programming problem.
When an empty cluster is created, the calculation of cluster center variance will be
invalid. To avoid this, we use a simple splitting procedure to handle empty clusters.
Specifically, if there is an empty cluster in V (d) (i.e. the whole column is 0) we randomly
split the largest cluster into two clusters. This procedure is repeated until there are
exactly k clusters. The full scVDMC algorithm is shown in Algorithm 5.
4.2.3 Upper bound of parameter w
Equation (4.5) is a sum of a few quadratic terms of variable U
(d)
i,: . The global minimum
of U
(d)
i,: can be solved in closed-form if the Hessian below is positive semi-definite,
H = V (d)
T
V (d) − 2wM
k
. (4.8)
In the following, we show that an upper bound on w will guarantee that H is positive
semi-definite. By Gershgorin circle theorem1 , the sufficient condition of H  0 is
Hii−
∑
j 6=i |Hij | ≥ 0 for ∀i. This is equivalent to stating that H is diagonally dominant
and only has non-negative diagonal entries. H can be rewritten as follows,
Hii = ci +
2w(1− k)
k2
, ∀i = 1, ..., k
Hij =
2w
k2
, ∀i 6= j,
where ci is the i
th diagonal entry of matrix V (d)
T
V (d), i.e., the size of cluster i. Then
we have
ci +
2w(1− k)
k2
≥ 2w(k − 1)
k2
1 For any eigenvalue δ of matrix H, |δ − Hii| ≤ ∑j 6=i |Hij | for ∀i ⇐⇒ Hii −∑j 6=i |Hij | ≤ δ ≤
Hii +
∑
j 6=i |Hij |.
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and thus,
w ≤ k
2ci
4(k − 1) ≤
k2cmin
4(k − 1) ,
where cmin as the minimum of ci, ∀i = 1, ..., k. Since cmin ≥ 1, we obtain a loose upper
bound of w = k
2
4(k−1) . In all the experiments, we set w to be smaller than the upper
bound for feasible implementation.
4.2.4 Related work
Most existing methods focus only on sub-population clustering and differential gene
expression detection among the learned cell clusters with one (pooled) cell population.
Some of these methods were directly adopted from traditional bulk RNA-seq analysis
and/or classical dimension reduction algorithms such as Principal Component Analysis
[33–35], hierarchical clustering [36], t-SNE [37–39], Independent Component Analysis
[40] and Multi-dimensional Scaling [41]. Other methods focus on special properties of
scRNA-seq data, such as high variance and uneven expressions. For example, SNN-Cliq
[42] uses a ranking measurement to get reliable results on high dimensional data; [43]
proposed a special dimension reduction method to handle the large amount of zeros in
scRNA-seq; [44] proposed a Latent Dirichlet Allocation model with latent gene groups
to measure cell-to-cell distance.
Mixed multiple batch strategy has been proposed [36, 45] to reduce the technical
variance, which does not directly improve clustering. To the best of our knowledge,
multitask clustering with an embedded feature selection has not been previously applied
to scRNA-seq data analysis.
4.3 Experiments
We applied scVDMC to two existing scRNA-seq datasets and compared the clustering
results with four baseline methods: (1) k-means clustering on each domain separately,
(2) pooling all domains and applying k-means clustering, (3) SNN-Cliq [42], and (4)
CellTree [44]. Pooled k-means (2) was used to obtain the initialization for scVDMC.
To apply the SNN-Cliq method in (3), we used the provided MATLAB code to
transform the data into the SNN graph, then used the Python code to produce the
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Figure 4.2: Clustering performance on mESC and lung epithelial scRNA-seq
datasets. (A) & (C) show the clustering results of the scVDMC algorithm with varying
numbers of selected marker genes compared with the four baseline methods. (B) & (D)
show the PCA of scVDMC, pooled k-means, and separated k-means results on the
selected top 20 marker genes. For each dot, the layer (outer) color indicates the true
cell type, while the inner color indicates the predicted cell type. The hyper-parameters
for scVDMC are λ = 20, w = 0.1 on the mESC dataset and λ = 30, w = 0.1 on the lung
dataset.
clustering result by ranking measurement. There are three hyper-parameters: k (size
of the nearest neighbor list), r (parameter for quasi-clique finding, range (0,1]), and m
(parameter for cluster merging range (0,1]). We tested multiple combinations of the
three hyper-parameters using k = 3, 5, 7, r = 0.1, 0.2, . . . , 0.9 and m = 0.1, 0.2, . . . , 0.9.
We also required the program to annotate all the data instead of leaving singletons
unlabeled (−n). Since SNN-Cliq identifies the number of clusters automatically, we
only reported the results with the correct number of clusters.
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To apply the CellTree method in (4), we used the provided R package to first fit a
Latent Dirichlet Allocation (LDA) model with the default method (joint MAP estima-
tion) to choose the number of topics followed by learning a pair-wise distance for all
cells. Then we ran hierarchical clustering with four different methods for computing
cluster distance (‘ward’, ‘complete’, ‘single’, ‘average’) and selected the best clustering
results.
For baselines (1) and (2), we followed a similar idea to choose marker genes. Af-
ter clustering, we chose the genes with large variance among the clusters as markers.
Since (3) and (4) use a different strategy for clustering and do not provide marker-gene
selection, we only focused on the clustering result for these two baselines.
4.3.1 Mouse embryonic stem cell (mESC) dataset
We downloaded the single-cell expression data for 250 mESCs [96] from the European
Bioinformatics Institute’s (EBI) ESpresso database. These 250 mESCs were cultured
in serum conditions and were captured using the Fluidigm C1 on three different days
from three different passages (biological replicates, n = 81, 90, and 79). After removing
genes expressed uniformly within a single replicate, 12,114 genes remained. For the
SNN-Cliq method, we further removed genes with an average expression less than 20
and log-transformed the data, as recommended in [42].
Figure 4.2(A) shows the clustering results. Compared with the four baselines,
scVDMC shows a consistently lower error with different choices of λs. Within a rea-
sonable range of λ, such as from 20 to 300, scVDMC shows significant improvement
compared with the other baseline methods. When λ is too small, such as 10 genes
selected, there are not enough markers to capture the difference among the cell types so
the error is larger. When λ is too big, scVDMC will consider almost all the genes and
the variance selection will not play a role. As such, scVDMC will eventually degrade
into separated k-means and the error will also increase. It is worth noting that the
results are not sensitive to the parameter w, for which the upper bound for w is 98 in
this case. It is also interesting that the CellTree method performed better than pooled
and separated k-means, while SNN-Cliq performed better than separated k-means but
worse than pooled k-means. Figure 4.2(B) shows the detailed clustering results by
scVDMC, pooled k-means and separated k-means. Compared with the pooled k-means
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and separated k-means, scVDMC captures relatively high variance in the leading prin-
ciple components and achieves improved clustering in every domain (fewer mixed-color
dots).
Analysis of the mESC transcriptome data using scVDMC yielded comparable re-
sults on marker gene selection to the hierarchical clustering in the original paper as
well as pooled and separated k-means. Both analyses were able to detect and highly
rank the known markers for differentiation Krt8, Krt18, Anxa1, Anxa2, Anxa3, Acta1,
and Acta2. Further, scVDMC detected several additional genes that pooled k-means,
separated k-means and the original paper did not. These included Dppa5a, a core
pluripotency gene for mESCs [97] and Igf2, a growth factor that promotes endothelial
differentiation in embryonic stem cells [98].
4.3.2 Experiment on lung epithelial single-cell data
We downloaded the single-cell expression data for 80 embryonic mouse lung epithelial
cells [99]. These 80 single-cell samples were taken from three different mice (biological
replicates, n = 20, 34, and 23) and contained five cell types: ciliated, Clara, AT1, and
AT2 cells, as well as a bi-potential progenitor (BP). Since only one replicate contained
ciliated cells, we removed these from the analysis, leaving 77 single-cell samples. After
removing genes expressed uniformly within a single replicate, 7,357 genes remained. For
the SNN-Cliq method, we further removed genes with log-transformed average expres-
sion less than 2.
With the limited number of single-cell samples in this dataset, scVDMC still im-
proved clustering over the baselines in the range of λ ∈ [30, 100] shown in figure 4.2(C).
In Figure 4.2(D), PCA plots of the top 30 genes show a trend similar to the ESC dataset,
where scVDMC’s top genes capture more variance and show less clustering error. Both
SNN-Cliq and CellTree performed better than pooled k-means and separated k-means,
with SNN-Cliq leading CellTree by a very small margin.
Analysis of the mouse lung epithelial transcriptome data using scVDMC yielded
comparable results to the hierarchical clustering in the original paper as well as pooled
and separated k-means. Both analyses were able to detect and highly rank the known
marker genes of the different cell types: Clara (Scgb1a1), AT1 (Pdpn, Ager), and AT2
(Sftpc, Sftpb). Further, scVDMC detected several additional genes that pooled k-means,
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separated k-means and the original paper did not. These included several components of
the Notch signaling pathway (Notch1, Jag1, and Nrarp) previously shown to be critical
for development of lung alveolar spaces, with AT2 cells being major sites of Notch
activation [100].
4.4 Analysis of RDEB scRNA-seq data
Recessive Dystrophic Epidermolysis Bullosa (RDEB) is an inherited blistering disor-
der caused by loss-of-function mutations in the COL7A1 gene that codes for type VII
collagen (C7) [101]. C7 forms the anchoring fibrils that attach the epidermis to the
dermis [102]. When C7 is missing, the skin becomes extremely fragile, eroding at the
slightest touch. From birth, patients with this disease must undergo intensive bandag-
ing and daily wound care. They are also susceptible to a highly aggressive form of
squamous cell carcinoma. [103–106]. It has been shown that allogeneic hematopoeitic
cell transplant (HCT) can partially rescue the RDEB phenotype. Cells from the bone
marrow home to the skin and deposit C7 at the dermal-epidermal junction, greatly im-
proving skin integrity in a subset of patients [107]. However, the molecular mechanism
by which this occurs remains unknown.
To identify sub-populations producing homing signals that could attract bone marrow-
derived cells to injured skin, we captured single dermal fibroblasts from patients with
severe generalized RDEB and their HLA-matched healthy siblings using the Fluidigm
C1 system. In total, 295 patient cells and 248 sibling cells were captured and sequenced.
Paired-end 75bp reads were mapped to the UCSC human transcriptome (hg19) using
Bowtie 2 (version 2.2.4) and Tophat (version 2.0.9). Gene expression levels were cal-
culated using Cuffquant (Cuﬄinks version 2.2.1 with parameters -u -max-bundle-frags
10000000) and Cuffnorm (Cuﬄinks version 2.2.1). FPKM values as estimated by Cuf-
flinks were added a value of 1 (to avoid zeros) and log-transformed. We excluded low-
expressed genes (average log2 (FPKM) < 1.5) from further analysis. All of our samples
met the requirement of expressing at least 2,000 of these remaining 5,196 genes.
Applying scVDMC to our RDEB single-cell dataset identified several top 100 genes
previously known to be involved in RDEB (Figure 3). These included CXCL12/SDF1,
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Figure 4.3: Single-cell sample clustering by 100 markers genes on the RDEB
data with scVDMC. The solid vertical red lines separate the cell clusters and the black
dashed horizontal lines indicate marker gene clusters derived by hierarchical clustering.
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the ligand for CXCR4, which directs cells of the bone marrow to damaged tissue includ-
ing skin [108] and HMGB1, which has shown to be positively correlated with RDEB
severity [109] and also mediates recruitment of bone marrow-derived cells to injured
tissue [110]. Note that we empirically removed confounding cell cycle genes from the
top 100 predicted markers and repeated scVDMC until there were no selected cell cycle
genes.
We also identified several genes as markers not previously associated with RDEB.
These included COL11A1, a minor fibrillar collagen shown to mark activated cancer-
associated fibroblasts (CAFs) that is not typically expressed in fibroblasts associated
with inflammation and fibrosis [111]. scVDMC also revealed GREM1, a BMP antagonist
associated with renal and pancreatic fibrosis [112, 113] and MFAP5, which promotes
attachment of cells to micro-fibrils of the extracellular matrix and interacts with TGBβ
growth factors [114]. We performed flow cytometry on the same RDEB patient and
matched sibling fibroblasts to validate the expression levels of these genes at the single-
cell level and found the results similar to our RNA expression data (Figure 4). As top
hits, these genes potentially mark sub-populations of stromal cells that contribute to
the transformation of the overlying epithelium and the development of squamous cell
carcinoma in RDEB patients.
It is also possible to apply other multitask learning or transfer learning methods
[48] for the clustering tasks. scVDMC is a multitask clustering method specifically
designed for scRNA-seq data for selection of a smaller set of cell-type markers and
allows large variability in gene expression across the cell populations. Other methods
are often built using different assumptions of the data that might not be applicable to
the characteristics of scRNA-seq populations [49,56,57].
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Figure 4.4: Validation of the novel markers by flow cytometry. The distribution
of expressions for novel genes was similar between flow cytometry experiments (top) and
the single-cell RNA-seq data (bottom) for the genes COL11A1, GREM1, and MFAP5.
RDEB patient single-cells are shown in red; matched sibling single-cells are shown in
blue. Flow cytometry data are measured as percent of max; RNA-seq data measured
in FPKMs.
Chapter 5
Conclusion and Discussion
5.1 Conclusion
Biomarker detection is important as it provides better prognosis and diagnosis for dis-
ease and further understanding on population genetics. Learning biomarkers among
subgroups is not only more accurate and robust as false positive signal are reduced
by only considering similar samples/patients/cells, but it also has advanced biological
meaning: for population study, accurate detection of population-differentiation CNV
can depict human evolutionary relations; for cancer research, causative and potential
therapeutic strategies can be systematic learned from tumor stage specific genes; on
single-cell level, understanding cell type specific biomakers provides chance to charac-
terize subpopulation structure, understand disease progression and mechanisms of tran-
scription regulation. However, there are still challenges, which described in introduction
section. In this thesis, we have presented several structured latent feature based and
multitask learning based methods to address these challenges and achieved improvement
on biomarker detection among subgroups for both CNV data and scRNA-seq data.
Our previous work SubPatCNV [16] demonstrates that population specific CNV
patterns widely exist. Therefore, we developed a structured latent feature based method
for high accurate CNV pattern detection for population studies. This tree-guided ma-
chine learning algorithm treeSGS is able to detect population-differentiation CNVs
among population subgroups and the population subgroups are organized by a phylo-
genetic tree of human populations. This algorithm dynamically splits populations into
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groups and sparsely selects subgroup-specific latent CNV features. Those learned latent
CNV features exhibit the preserved CNV patterns from the ancestral population. Ex-
periments on Hapmap3 dataset with 11 populations show that, comparing with method
that not using hierarchical tree structure and method without sparse selection on sam-
ple subgroups, our proposed treeSGS model achieves high accuracy on detecting a list
of candidate AIM CNV markers that not only are population-differentiation but also
depict the evolutionary relations among the populations.
Then, to study CNVs across different cancer domains, we proposed TLFL algorithm,
which uses latent features model combined with transfer learning technic. In this model,
each cancer type can be regarded as one domain in transfer learning and common latent
CNV features are used as a bridge to transfer knowledge among different cancer domains
while domain-specific components are preserved for each cancer type to explain the
heterogeneity of each cancer. Fused lasso is also applied on each latent CNV features
to preserve the sparsity and block structure of CNV patterns. Experiments on cross
cancer type study show that TLFL is more accurate on detect cancer related CNVs
comparing with non-transfer-learning model.
Finally, we proposed a multitask learning method with an embedded feature selec-
tion (scV DMC) on single-cell RNA sequencing data. This algorithm was specifically
designed for scRNA-seq data with multiple samples or multiple experiments by cap-
turing the most differentially expressed genes among cell type clusters across all the
domains. Since sample heterogeneity and experiment bias play a big role in the diver-
gence of RNA expression on single cells, scV DMC utilizes a variance-driven multitask
clustering method to capture shared cell-type bio-markers. The experiments on two real
single-cell RNA-seq datasets with several replicates show that scV DMC detected more
accurate cell populations and known cell markers than pooled clustering and several
other recently proposed scRNA-seq clustering methods. Experiment on in-house Reces-
sive Dystrophic Epidermolysis Bullosa (RDEB) scRNA-seq data also revealed several
interesting cell types and markers that were previously unknown.
In summary, all models proposed in this thesis showed promising results in both
simulations and experiments on CNV and scRNA-seq data. The proposed algorithms
are useful computational tools for population research and disease studies.
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5.2 further work
In this section, we will discuss some limitation of our current methods and propose
several further work and directions.
5.2.1 treeSGS
Human phylogenetic tree depicts the relations among populations in a hierarchical way.
Our proposed treeSGS method utilizes this structure as prior information and success-
fully learns tree-constraint-subgroup specific CNV patterns.
One potential direction to expend this idea is to cooperate more detailed sample
relation as prior knowledge to guide CNV learning, such as the father-mother-child
trio information, which is available in Hapmap data and 1000 Genome Project. These
additional information could either be combined with phylogenetic tree to build more
complicated tree structure, or separately applied as additional constraint on coefficient
matrix. Keep in mind that if the tree structure is getting complicated, the tree split
hyper-parameter would play a more important role in identifying subgroups and there-
fore fine tuning would be needed to get a balance between easy explanation and reserving
low level sample relations.
Even through this method is developed for population genetic study, it is also possi-
ble to be used for pan-cancer CNV research. Currently, the major obstacle for utilizing
treeSGS on pan-cancer study is that reliable cancer type relationship is not available.
It is not a trivial problem to get pan-cancer relationship as the knowledge of functional
impacts of CNVs on cancers is quite fragmented and pathophysiological role are not
fully understand. To overcome this, One solution is to use partially known pan-cancer
relations but leave the unknown or uncertain cancer relation unconstraint by always
splitting among them in treeSGS. Modified algorithm will be needed to address this
situation.
5.2.2 TLFL
Application of transfer learning on CNV analysis across multiple cancer types is promis-
ing since CNVs are a hallmark of cancer genomes. TLFL enables sharing information
in datasets of different cancer domains to discover latent CNV features that can explain
75
common and domain-specific cancer characteristics and better classify patient samples.
It is expected that transfer learning will play an important role in the comparative anal-
ysis of the large patient cohorts to improve the current knowledge of cancer development
and progression in the light of both common and specific cancer CNVs.
However, there is limitation of TLFL model on handling large number of cancer
types. This is because the definition of ”common” latent CNV features in TLFL is
very strict: they have to be shown in all the cancer type domains. As the number
of cancer types to be learned in the model increasing, the number of ”common” latent
features will decrease. For example, on a study with 10 different cancer types, there may
be no latent CNV features across all of them, but there are CNV regions shared between
breast cancer and ovarian cancer, such as regions related with gene BRCA1. Without
utilizing these ”partially common” relationship will decrease the power of accurate CNV
learning. To solve this problem, the aforementioned treeSGS model could be a solution
as long as cancer type relations are depicted. Another possible strategy is applying
TLFL multiple times, with each time solving a few related cancer types. The overall
optimization problem is the summation of each TLFL subproblem.
Combining prior-known clinical group information could be another direction to
improve TLFL method for accurate biomarker detection. Currently TLFL method
doesn’t assume any sample groups within each cancer domain. With additional sample
information in each domain available, such as tumor stage or tumor grade, latent CNV
features could be identified not only domain specific or common among domains, but
also assigned to specific group(s) within certain domain. Below is a possible framework,
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which combines TLFL with SGS − FL [60]:
min
δ∑
d=1
(
1
2
||Xd − [Uˆ , Ud]Vd||2F
+λd
k−τ∑
j=1
m∑
i=1
|Ud(i,j)|+ γd
k−τ∑
j=1
m∑
l=2
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τ∑
j=1
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τ∑
j=1
m∑
l=2
|Uˆ(l,j) − Uˆ(l−1,j)|,
s.t.
Vd ≥ 0 and Vd(i,:)V Td(i,:) = 1 for i = 1, 2, . . . , k,
Vd(i,gdl )
× bd(i,gdl ) = 0 for i = 1, 2, . . . , k,
(5.1)
where gdl is the selected samples from group l on domain d.
5.2.3 scVDMC
There are limitations in the scV DMC method. In multitask clustering, assuming a
global k as the number of clusters in each cell population dataset does not always hold
true as for some rare cell types, the corresponding cells may only be present in some
populations. scV DMC might incorrectly split a cluster of one cell type because no
empty cluster is allowed. One possible improvement is to model each domain with an
individual k(d) with a more adaptive strategy for choosing k(d). In this case, the overall
balance between within-cluster distance and the variance will need to be more carefully
weighted. In addition, cell cycle-related genes could be a large source of confounders.
Unless the stages of cell cycle are the biological signal under study, cell cycle-related
variation could obscure biological signals of interest. It is possible to model the con-
founders directly in the scV DMC method with complex modeling. Alternatively, we
could pre-process the scRNA-seq data to remove the cell cycle signals. For example, a
Gaussian processes-based latent-variable model [115] was used to account for confound-
ing variations due to the cell cycle in scRNA-seq data sets and then linear regression
was applied to remove them. In this approach, a clearly defined cell cycle gene set is
necessary to avoid removing true signals unexpectedly.
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